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ABSTRACT 
Direct Plasma Interaction with Living Tissue 
Gregory Fridman 
Dr. Gary Friedman, Dr. Kenneth Barbee 
 
 
For some time, plasma has been used in medicine to cauterize or cut tissue using heat 
and  mechanical  energy.  In  the  recent  decade,  some  researchers  around  the  world 
have  started  to  investigate  how  gas  jets  that  pass  through  thermal  plasma  can  be 
employed in medicine. This thesis presents the first investigation of biomedical uses 
of non‐thermal plasma discharge which comes in direct contact with living tissue. It is 
demonstrated that the direct application of non‐thermal plasma in air can cause rapid 
deactivation  of  bacteria  on  surfaces  of  tissues  without  causing  any  visible  tissue 
damage. Medical need  for such a device  is discussed. Construction and operation of 
various  types  of  non‐thermal  plasma  power  supplies  and many  types  of  treatment 
electrodes  are  presented  as  well.  Application  of  this  plasma  to  living  organisms  is 
shown  to  be  safe  from  both  the  electrical  perspective  and  from  the  biological 
perspective. Biological safety is revealed through a series of differential skin toxicity 
trials  on human  cadaver  tissue,  live  hairless mouse  skin  tissue,  live  pig  skin  tissue, 
and  finally  in  an  open  wound  model  on  pigs.  Direct  non‐thermal  plasma  in  air  is 
shown  to deactivate bacteria about 100  times  faster  than  indirect application using 
jets. A series of experiments reveal that this effectiveness is due to the ability of direct 
discharge  to  bring  charges  to  tissue  surfaces.  It  is  demonstrated  that  neither 
ultraviolet  (UV)  radiation  nor  neutral  active  species  such  as  hydroxyl  radicals  or 
ozone produced  in plasma are responsible  for  the main effect on bacteria. Although 
iv 
much additional work remains on establishing detailed mechanism by which charges 
from  plasma  achieve  this  effect,  the  work  carried  out  in  this  thesis  clearly 
demonstrates that direct application of non‐thermal plasma in air can be a very useful 
tool in medicine.  
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CHAPTER 1. DIRECT NON-THERMAL PLASMA MEDICINE 
VERSUS CONVENTIONAL THERMAL AND JET PLASMA 
TREATMENT OF LIVING TISSUE 
 
In physical sciences, “plasma” refers to the forth state of matter; while in medicine and 
biology “plasma” is mostly known as the non-cellular fluid component of blood. 
Interestingly, the term plasma has been coined by Irving Langmuir to emphasize that the 
characteristics of ionic liquids ubiquitous in biology and medicine are analogous to those 
of ionized gas [1]. Despite this historical connection, few applications of plasma in 
medicine have been explored until recently [2]. This situation is rapidly changing, and in 
this thesis we will discuss a new non-thermal atmospheric pressure plasma system which 
can effectively inactivate bacteria on human tissue without damaging it. 
Plasma can exist in a variety of forms and can be created in different ways. In many 
technological applications, for example, plasma exists at low gas pressures. Lightning, on 
the other hand, is an example of atmospheric pressure thermal plasma. For the purpose of 
this work it is important to distinguish between thermal and non-thermal plasma. In all 
plasmas supported by electric field, electrons receive the external energy much faster than 
much heavier ions. Electrons have the opportunity to heat up to several thousands of 
degrees before their environment heats up. In non-thermal plasma, cooling of ions and 
uncharged molecules can be highly effective compared with the energy transfer from 
electrons. As a result, gas remains at low temperature. Since electrons and gas are at very 
different temperatures, non-thermal plasma is also called non-equilibrium plasma. In 
thermal plasma, on the other hand, energy flux from electrons to heavy particles 
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equilibrates the energy flux from heavy particles to the environment only when 
temperature of heavy particles becomes almost equal to the electron temperature. Of 
course the terms thermal and non-thermal, equilibrium and non-equilibrium are not very 
precise. Sometimes even a few tens of degrees difference in the temperature of the heavier 
species can play a substantial role. This is particularly important when various plasma-
chemical processes are considered. It is certainly important when plasma is used to treat 
heat sensitive objects. 
Some of the earlier applications of plasma in medicine relied mainly on the thermal effects 
of plasma. Heat and high temperature have been exploited in medicine for a long time for 
the purpose of tissue removal, sterilization and cauterization (cessation of bleeding) [3]. 
Warriors have cauterized wounds by bringing them in contact with red hot metal objects 
since ancient times. Electrocautery is a more modern technique which applies controlled 
heat to surface layers of tissue by passing sufficiently high current through it [4]. However, 
contact of tissue with metal surface of a cautery device often results in adhesion of charred 
tissue to the metal. Subsequent removal of the metal can peel the charred tissue away re-
starting bleeding. Some of the earlier applications of plasma in medicine provided an 
alternative to metal contact electrocautery. In argon plasma coagulation (APC, also 
sometimes called argon beam coagulation) highly conductive plasma replaced the metal 
contacts in order to pass current through tissue avoiding the difficulties with tissue 
adhesion. Hot plasma is also being employed to cut tissue [3, 5-8], although the exact 
mechanism by which this cutting occurs remains unclear. Heat delivered by plasma has 
also been employed recently for cosmetic re-structuring of tissue [9-11]. 
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What differentiates more recent research on applications of plasma in medicine is the 
exploitation of non-thermal effects. Why are non-thermal effects of plasma so interesting 
and promising? The main reason is that non-thermal plasma effects can be tuned for 
various sub-lethal purposes such as genetic transfection [12-14], cell detachment [15-18], 
wound healing [19-23], and others (i.e., [2, 24, 25]). Moreover, non-thermal effects can be 
selective in achieving a desired result for some living matter, while having little effect on 
the surrounding tissue (Figure 1). This is the case, for example, with recent plasma blood 
coagulation and bacteria deactivation which does not cause toxicity in the surrounding 
living tissue [19, 20]. 
 
Figure 1. Photograph of the Floating Electrode Dielectric Barrier Discharge (FE-DBD) plasma in 
direct contact with living tissue. 
Most of research focusing on the use of non-thermal plasma effects in medicine can be fit 
into two major categories: that are direct plasma treatment and indirect plasma treatment. 
Direct plasma treatment has been pioneered at Drexel University (see Fridman, Shekhter, 
4 
Vasilets, et al, 2008 [26]). In direct plasma treatment living tissue or organs play the role of 
one of the plasma electrodes. Voltage does not need to be directly connected to this living 
tissue electrode, but some current may flow through living tissue in the form of either a 
small conduction current, displacement current or both. Conduction current should be 
limited in order to avoid any thermal effects or electrical stimulation of the muscles. Direct 
plasma treatment may permit a flux of various active uncharged species of atoms and 
molecules as well as UV radiation to the surface of the living tissue. These active 
uncharged species generated in plasma will typically include ozone (O3), NO, OH radicals, 
etc. However, the most important distinguishing feature of the direct plasma treatment is 
that a significant flux of charges reaches the surface of the living tissue. These charges may 
consist of both electrons as well as positive and negative ions. 
In contrast, indirect plasma treatment employs mostly uncharged atoms and molecules that 
are generated in plasma, but involves small, if any, flux of charges to the surface. In 
indirect treatment the active uncharged species are typically delivered to the surface via 
flow of gas through a plasma region. 
Both indirect and direct non-thermal plasma treatments permit some degree of tuning of 
the plasma properties [27]. For example, the amount of NO vs. ozone produced in plasma 
can be tuned. It is also possible to tune micro-structure of the plasma discharge which can 
be particularly relevant in direct treatment. The fact that direct plasma treatment involves 
substantial charge flux provides greater flexibility in tuning the non-thermal plasma 
effects. Indirect plasma treatment, on the other hand, may have an advantage when the 
plasma device needs to be at a substantial distance from the surface. 
5 
In this chapter we will discuss current status of various plasma systems from many 
research groups around the world in their applications to medicine. The mode of operation 
of these plasmas will be specifically pointed out: is the plasma thermal or not, how is it 
generated, and what are some of the benefits and drawbacks. 
 
1.1. Sterilization of Non-Living Objects for Medical Applications: a Review 
Traditionally, sterilization or treatment of non-living objects like metals, plastics, fabrics, 
and other surfaces have been carried out either by temperature (i.e., autoclaves [28-31]), 
liquid or gaseous chemistry (i.e., by ethylene oxide [32, 33], ozone [34, 35], chlorine [36, 
37], etc.), or at reduced pressure by non-equilibrium plasmas [38, 39]. Details of such 
approaches are widely available in literature. Here we will focus on medical application of 
non-equilibrium plasma at atmospheric pressure and surface sterilization of materials 
cannot then be overlooked because, after all, these materials later come in contact with 
living tissue either as implants, dressings, tools, etc. 
Drs. Alexeff and Laroussi and their colleagues reported a rather interesting modification of 
a conventional dielectric barrier discharge – a Resistive Barrier Discharge (RDB) [2, 40, 
41]. Main feature of the RDB is that is can function in both DC and AC modes, and rather 
than a dielectric a wetted high resistivity material is used. RDB has been shown to be 
effective in sterilization of E. coli, B. subtilis, and other organisms [2, 41, 42] without 
significant damage to the surface being processed. Going back to a more traditional DBD 
system, Laroussi and his colleagues [43-46] show that a barrier discharge in helium with 
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small additions of oxygen is not only able to sterilize bacteria but is able to influence 
metabolic changes in the organisms surviving the treatment [44]. This raises an intriguing 
question – can plasma-resistant bacteria emerge? Due to synergetic effect of plasma 
constituents on bacteria, plasma-resistance might not be possible or statistically probable, 
however, the authors think that this issue might become rather important in the near future 
and should be addressed. Two more discharges are studied by Dr. Laroussi and colleagues: 
plasma plume (a helium jet) [47, 48], and an arc-like discharge between metal and water in 
air [49, 50]. Both discharges are also reported to efficiently inactivate various micro-
organisms. 
Dr. Massines and her colleagues propose a DBD discharge in N2/N2O mixture for micro-
organism inactivation (i.e., B. subtilis spores) [51-53]. Operated at atmospheric pressure, 
her results indicate a very high dependence of the inactivation efficiency on UV, which is 
somewhat contrary to results presented by other groups [51]. In fact, the difference is 
attributed to the fact that the gas composition necessary to achieve the best results is in a 
very narrow concentration range of the oxidant molecule, which might have simply been 
overlooked previously. Though this study offers good information on UV, a real-life 
environment might need a system that is slightly less picky as to the gas mixture 
concentration ranges. However, one needs to account for effects of ultraviolet radiation on 
bacteria as apparently they cannot be neglected, even in plasmas where doses of UV are 
lower than in that proposed by Dr. Massines [51]. 
Microplasmas have recently been gaining momentum in bio-medical applications. These 
systems of 10-500 µm characteristic dimensions capable of generating diffuse atmospheric 
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pressure plasmas offer an interesting solution in, for example, medical diagnostics and 
environmental sensing. Dr. Becker and colleagues [54, 55] offer a few different 
microplasma sources suitable for remediation of gaseous waste streams, removal of 
volatile organic compounds (VOCs), detection of trace contaminants in gas flow, 
generation of high intensity ultraviolet (UV) radiation, and sources suitable for micro-sized 
plasma-reactors. Though the temperature of these discharges can be at or near room 
temperature in noble gases, when a molecular gas (i.e., air) is used plasma temperatures 
can be high, on the order of 2,000 K. Dr. Becker et al. show efficient inactivation of B. 
subtilis spores (1 log reduction in ~100 seconds) and B. stearothermophilus spores (1 log 
reduction in ~90 seconds) without damage to the substrate; more interestingly they are able 
to inactivate bio-films of Chromobacterium violaceum CV026 achieving 2 log reduction in 
~ 5 minutes and 3 log reduction in ~60 minutes of plasma afterglow treatment [54]. In 
general, these microplasmas have not yet found a niche in medicine directly through many 
potential applications are clearly possible and the reader is encouraged to take a look at a 
review of the recent developments in that field [55]. 
Dr. Roth and his colleagues have developed a one atmosphere uniform glow discharge 
plasma (OAUGDP) system capable of addressing a broad range of potential applications 
[56-62]. OAUGDP is a DBD-like bipolar RF plasma discharge operated in air or other 
gases. The list of potential applications where experimental evidence is very favorable 
includes increasing surface energy and wettability of fabrics, films, and solid surfaces; 
sterilization of various surfaces for healthcare and food processing; decontamination of 
surfaces compromised by chemical or biological warfare agents; a sterilizable air filter to 
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deal with the sick building syndrome [63]; removal of soot and volatile organic compounds 
from Diesel engine exhaust; mercury-free atmospheric pressure fluorescent lamps; 
stripping of photoresist and directional etching in microelectronics; plasma assisted 
chemical vapor deposition; and plasma aerodynamic flow control. For details on these 
applications reader is encourages to consult a recent publication by Dr. Roth et al. [60]. Of 
note, however, is a less recent publication from Dr. Roth’s group comparing sterilization 
efficiency of their system against a multitude of bacteria, yeasts, and viruses [57]. D-
values, or time to 90% reduction in micro-organism load, are ranging from 6 seconds for 
E. coli bacteria to 6.8 minutes for Bacteriophage Phi X 174 virus. Additionally 
survivability of these organisms on different substrates is addressed comparing glass, agar, 
and polypropylene with the later showing highest survival times. In general, OAUGDP 
was not reported to be used in medicine directly; however, sterilization of medical 
instruments and other surfaces found in the hospital as well as air sterilization in an 
operating room is on the list of potential medical applications [60]. 
Dr. Kong and his colleagues have investigated inactivation of various organisms by pulsed 
electric field [64], and, primarily, by He/O2 RF plasma afterglow (or jet) [65-74]. Ability 
of their plasma setup to inactivate B. subtilis spores [65, 69] and various E. coli mutants 
[70] does not come as a surprise, however the results on inactivation of biofilm-forming 
bacteria are quite intriguing. Dr. Vleugels et al. [72] have successfully achieved 
inactivation of biofilm-forming Pantoea agglomerans in sterilization of foods, specifically 
of bell peppers (Capsicum annuum). He/O2 plasma afterglow was shown to effectively 
inactivate the biofilm without causing unacceptable levels of discoloration to the peppers 
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[72]. Detailed analysis of this system reveals that the primary role in inactivation is played 
by reactive oxygen species (e.g. atomic oxygen and OH) with minor aid from UV photons, 
charged particles, heat, and electric fields [65, 68, 70, 71, 73, 74]. Another interesting idea 
is not only sterilization of various surfaces but complete decontamination of them with 
removal not only of bacterial load but of the remaining protein debris. Deng et al. show 
that this RF plasma jet treatment can effectively remove proteins from surface of medical 
instruments, achieving up to 4.5 log reduction [66, 67]; here, again, reactive oxygen 
species are deemed to be the major inactivation factors. 
 
1.2. Plasma-Assisted Wound Healing and Tissue Regeneration: Discharge Systems for 
Air-Plasma Surgery and Nitrogen Oxide (NO) Therapy 
Effective use of hot plasma in surgery has been first demonstrated in 1960s: plasma 
afterglow jet of an inert gas has been applied for tissue sectioning with instant blood 
coagulation. Because of that plasma-surgical devices got a long-standing name of “plasma 
scalpel” in the hospitals (see, for example, Glover et al. [75]). An example plasma of a 
thermal plasma used in surgery for wound healing and tissue regeneration is the “Plazon” 
system based on the jet of hot air plasma rapidly quenched which provides relatively high 
NO concentration with significant therapeutic effect [76, 77]. This plasma device is used in 
two modes. In the first “hot mode” plasma jet is used for rapid coagulation and sterilization 
of wound surfaces, destruction and desiccation of dead tissue and pathologic growths, 
dissection of biological tissues. In the second “cold mode” NO-containing plasma gas flow 
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with temperature of 20 to 40°C is used for stimulation of regenerative processes and 
wound healing.  
The “Plazon” generators [21, 76, 77] are the DC arcs with different configurations of the 
exit channels corresponding to the different applications (blood coagulation, tissue 
destruction, therapeutic manipulation/stimulation). Main and common elements of the 
system construction are the liquid-cooled cathode, intra-electrode insert, and anode. 
Atmospheric air enters the manipulator through the built-in micro-compressor, passes 
through the plasma arc, heats up and thus accelerates, and exits through the hole in the 
anode of the plasma-generating module. Plasma temperature at the anode exit differs in 
different configurations of the device, corresponding to different medical applications. 
Further away from the anode, temperature drops rapidly, and at 30-50 mm from the anode, 
the flow is composed simply of the warm gas, and the plasma-generated NO. Nitrogen 
oxide content in the gas flow is mainly determined by the quenching rate. The necessary 
quenching rate for effective operation of the medical device is about ~107-108 K/sec. 
Commonly, the cooling rate of plasma jets is on the order of ~106 K/sec. Thus, to achieve 
the cooling rate of ~107-108 K/sec, it is necessary to utilize additional cooling of the 
plasma jet, which has been achieved by special construction of the plasma nozzles. 
The therapeutic manipulator-stimulator configuration of the “Plazon” discharge system is 
used solely for therapeutic treatment by exogenic nitrogen oxide. The principle difference 
of this manipulator is that the air-plasma jet does not freely exit into the atmosphere, but 
rather it exits the anode into the two-step cooling system, gas channels of which are created 
in a maze scheme to force-cool the jet by the liquid circulating from the cooling system. 
11 
This construction allows one to obtain NO-containing gas flow (NO-CGF) with 
sufficiently low temperature, and optimal concentration of nitrogen oxide molecules, 
which makes it possible to apply this manipulator for treatment of external body surfaces 
by using the cooling hose of 150 mm length (temperature of NO-CGF at the exit ~36 °C). 
Of course, NO content in the gas flow depends on the distance from the exit channel. 
Additionally, for laparoscopic operation, a special manipulator of 350 mm length and 10 
mm diameter is utilized. 
The possible operating regimes of the apparatus are defined by the characteristics of the 
gas flow exiting from the manipulator, main parameters of which are its temperature and 
the nitrogen oxide content. First group of regimes – regimes of free-flowing plasma off-gas 
exiting the manipulator; second group of regimes – regimes of treatment of bio-tissues by 
completely cooled (20ºC) NO-containing gas flow, to obtain which a manipulator is 
connected to the internal gas cooler, and delivery of NO-CGF to bio-tissues is achieved 
through a silicone tube with an attached tip of 130 or 390 mm length, and the exit channel 
diameter of 0.7 mm. This allows not only direct treatment of the bio-tissues by NO, but 
also its delivery to a pathologic center through drainage tubes, puncture needles, or any 
endoscopic devices (gastroscope, broncoscope, cystoscope, rectascope, etc).  
The Nobel Prize in medicine and biology was awarded in 1998 to R. F. Furchgott, L. J. 
Ignarro, and F. Murad for their work in investigation of function of nitrogen oxide as a 
signal molecule [78]. Today it is well known that in a human organism, NO serves a 
multitude of essential biological functions – it regulates blood vessel tone (via relaxation of 
flat epithelial cells) and blood coagulation, immune system and early apoptosis, neural 
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communication and memory, relaxation of flat bronchial and gastrointestinal muscles, 
hormonal and sex functions, NO offers antimicrobial and antitumor defense, etc. In 
pathology, NO plays a major role in adaptation, stress, tumor growth, immunodeficiency, 
cardiovascular, liver, and gastrointestinal tract disease, etc. This explains wide possibilities 
of the plasma-generated exogenic NO in multiple medical applications. 
Importance of exogenic NO in infection and inflammation processes is also well studied 
and is linked with antimicrobial effects; stimulation of macrophages; induction of 
cytokines, T-lymphocytes, and many immunoglobulins; interaction with oxygen radicals; 
and influence on microcirculation, cytotoxic and cytoprotective role in different conditions. 
During inflammation, macrophages and some other cells (i.e. aibroblasts, epithelial cells, 
etc.) produce NO via inducible NO-synthase (iNOS) in quantities significantly greater (2 
orders of magnitude) than normal when NO is formed via constructional NOS: endothelial 
(eNOS) and neuronal (nNOS).  
Exogenic NO is also crucial in trauma wound processes. Activity of inducible NO-
synthase (iNOS) grows substantially in trauma wounds, burn wound tissues, bone fracture 
site tissues, and others in the inflammatory and proliferation phases of the healing process. 
Activation of iNOS was also discovered in cultivation of wound fibroblasts. Macrophage 
activation in a wound, cytokine synthesis and proliferation of fibroblasts, epithelization 
and wound healing processes are all linked with the activity levels of iNOS. In animal 
models, injection of iNOS inhibitors disrupts all of these processes and especially the 
synthesis of collagen, while NO synthesis promoters increase the rate of these processes. 
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Animals with iNOS deficiency demonstrate significant decrease in wound healing rate, 
however this can be reversed by injection of iNOS gene. In complicated wound models, 
for example in experimentally-induced diabetes, protein deficiency, injection of 
corticosteroids or immunosuppressants, and also in patients with tropic ulcers, lowered 
activity of iNOS is usually discovered which correlates to slowed healing processes. 
Exogenic delivery of NO-donors (nitrogen-containing compounds) to the wound promotes 
and speeds up healing processes in animals with complicated wounds and in animals with 
inhibited iNOS. This knowledge, coupled with theoretical and experimental data on NO 
generation in air plasmas, served as a basis for a series of bio-medical experiments focused 
on use of the plasma-generated exogenic NO, delivered directly to the pathologic site, for 
control of inflammatory processes and increase in the rate of wound healing. 
Possibility of directing of the plasma-generated NO-containing gas flows through puncture 
needles, vent lines, and endoscopic instruments, and also the inhalation method of action 
considerably enlarges prospects for the plasma NO-therapy in treatment of the ulcero-
necrotic, erosive and inflammatory processes in the pleural and abdominal cavities, lungs, 
stomach and bowels, ear nose and throat (ENT) organs (purulent sinusitis, purulent otitis 
media, paratonsillar abscesses), etc. Effectiveness of the plasma NO-therapy is already at 
present shown with a number of diseases in pulmonology [79], phthisiology [80], 
traumatology and orthopedics [21, 81], gynecology [82-84], dentistry [85], maxillofacial 
surgery [21], ophthalmology [86], otorhinolaryngology [87], dermatology [88], 
gastroenterology [89], purulent peritonitis [81], and in other applications discussed in 
further detail in our recent review [26]. 
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1.3. Non-Thermal Plasma Treatment of Various Diseases 
1.3.1. Non-Equilibrium Pulsed Spark Plasma Jet 
A special micro-plasma jet system has been developed by our collaborators for local 
medical treatment of skin diseases, and especially for treatment of corneal infections (see 
Fridman, Shekhter, Vasilets, et al, 2008 [26]). The device allows generation of plasma 
flows with average gas temperature not exceeding 30-40°C [22, 26]. It consists of a coaxial 
cathode and needle-like anode, which is fixed in metal capillary. The gas is fed through the 
capillary to the discharge gap. The anode is connected with the positive lead of the power 
source and the cathode is grounded. The discharge appears on the nozzle output if the 
pressure on the nozzle input is higher than the atmospheric pressure. The discharge is a 
specific plasma sphere with the diameter ~4 mm, atmospheric air or xenon are fed through 
the capillary at 0.2-0.5 atm, the discharge voltage is 1-3 kV, the pulse duration is about 50 
µs, the total power was kept on the order of 1-2 W. 
The medical micro-plasma operated in Xe radiates intensively in the UV range, and 
operated in air it generates excited oxygen species, ozone, oxides of nitrogen, and OH 
radicals [22]. Both regimes have bactericidal effects and air plasma is able also to aid in 
tissue regeneration via the NO-therapy mechanisms discussed above. UV-radiation of Xe 
plasma in this case is: UVA (315-400 nm) 180 μW/cm2, UVB (280-315 nm) 180 μW/cm2, 
and UVC (200-280 nm) 330 μW/cm2. UV-radiation of air plasma is: UVA (315-400 nm) 
53 μW/cm2, UVB (280-315 nm) 25 μW/cm2, and UVC (200-280 nm) 90 μW/cm2. Results 
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of probe measurements of current density, velocity, and ion concentration at different 
distances from the exit nozzle are shown in Table 1. 
Table 1. Dependence of the current density and ion concentration of the Xenon plasma flow on the 
distance [22]. 
Distance, mm  1 1.3 2 3
Current density, mA/cm2 2040 2000 240 60
Velocity, cm/sec  2∙104 1.8∙104 1.2∙104 7∙103 
Ion concentration, cm‐3 6.4∙1014 3.7∙1014 1.5∙1014 5.3∙1013 
 
Ability of the medical micro-plasma system to sterilize surface has been demonstrated by 
Misyn et al. [90-93]. Staphylococcus cultures in liquid media (~2·106 cfu/ml) have been 
treated by the air plasma plume of 3 mm diameter, incubated for 24 hours, and counted 
(Table 2).  
Table 2. Results of Staphylococcus inactivation by air plasma [22]. 
Culture volume, ml Plasma exposure time, sec
0 (control) 25 50 100
1  2∙106 cfu 0 cfu 0 cfu 0 cfu
2  4∙106 cfu 25 cfu 0 cfu 0 cfu
3  6∙106 cfu 1∙106 cfu 680 cfu 460 cfu 
 
A 6-log reduction in viable bacteria is achieved in 25 seconds of treatment; however the 
sterilization efficiency drops off with increasing volume of liquid which inhibits UV 
penetration and diffusion of active species generated in plasma. Nevertheless, the micro-
plasma system should be a good solution for treatment of living human and animal skin as 
the bacteria are normally at much lower concentrations on skin (<<105 cfu/cm2 of skin 
surface [94]). 
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A series of in vitro experiments on bacterial cultures and in vivo experiments on rabbit 
eyes [93] affirm the strong bactericidal effect of the micro-discharge with minimal and 
reversible changes, if any, in biological tissues, even in such delicate tissues as cornea. 
During the investigation of plasma treatment of ulcerous dermatitis of rabbit cornea two 
important observations were made: 1) plasma treatment has a pronounced and immediate 
bactericidal effect, and 2) the treatment has an effect on wound pathology and the rate of 
tissue regeneration and wound healing process. 
These results offered a strong ground for application of the medical micro-plasma system 
for treatment of human patients with complicated ulcerous eyelid wounds, which is shown 
in [93]. Necrotic phlegm on the surface of the upper eyelid was treated by air plasma 
plume of 3 mm diameter for 5 seconds once every few days. By the 5th day of treatment 
(two 5-second plasma treatment sessions) the eyelid edema and inflammation were 
reduced; and by the 6th day (third session) the treated area was free of edema and 
inflammation and granular tissue appeared. Three more plasma treatments were 
administered (six total), and the patient was discharged from the hospital six days 
following the last treatment. The micro-plasma treatment is being further developed for 
stimulation of reparative processes in various topical wounds, tropic ulcers, chronic 
inflammatory complications, and other diseases of soft tissues and mucous membrane [93]. 
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1.3.2. Non-Equilibrium “Plasma Needle” Treatment 
A radio frequency plasma source, a plasma needle, was recently developed by E. Stoffels 
et al. [18, 95-97]. Plasma needle is a flexible hand-held device (Figure 2) consisting of a 
0.3 mm diameter needle, 0.8 mm diameter Perspex tube, 10 cm in length. The plasma is 
generated at the end of the needle at the applied frequency of 13.56 MHz. This device was 
successfully demonstrated in treatment of various cell lines and inactivation of bacteria. 
Though the final goal of this plasma treatment is in treatment of dental cavities, localized 
and precise inactivation of cancerous tissues, and in other medical applications, at the 
moment deeper understanding of biological mechanisms of plasma-cell interaction 
mechanisms is being pursued [98]. Dr. Stoffels and her colleagues have thus-far worked 
with the following eukaryotic cells and bacteria [18]: 
 fibroblasts: Chinese hamster ovarian cells (CHO-K1) [99], 3T3 mouse fibroblasts, 
 muscle cells: rat aortic smooth muscle cells (SMC) (A7r5) [100], 
 endothelial cells: bovine aortic endothelial cells (BAEC) [100], 
 epithelial cells: human MR65 cells originating from non-small cell lung carcinoma 
(NSCLC) [101], 
 gram-positive bacteria: Streptococcus mutans, 
 gram-negative bacteria: Escherichia coli [102, 103], and 
 artery sections obtained from Swiss mouse (carotid and uterine arteries) [18]. 
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Figure 2. A principal schematic of the plasma needle setup [18]. 
Treatment by plasma needle of various cell lines causes these cells to lift off from the 
substrate and float away, without necrosis of these cells (Figure 3) [18]. The penetration 
depth of this treatment is usually limited to a single cell layer when no necrosis is observed 
while deeper treatment is possible at higher doses where cell necrosis is also observed. In 
addition to a well-localized detachment, apoptosis-like behavior was observed in the 
detached cells; however, the level of apoptosis appears to be not too significant as about 
3% of the human epithelial cells underwent apoptosis while 100% were detached [18]. Dr. 
Stoffels hypothesizes that the dosage requirement induction of apoptosis are very narrow 
and further investigation onto the biochemical mechanisms of apoptosis induction are 
necessary. In treatment of E. coli roughly a 2-log reduction in bacterial load was achieved 
in 60 seconds of plasma treatment at 100 mW, 1 cm away from the sample [18, 103]. 
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Figure 3. A void created in a cell culture, grown on a Petri dish. At the incidence of the plasma needle, 
the cells are removed (suspended in the medium and washed away) [18]. 
 
1.3.3. Indirect 6-Electrode Thermal Microwave Plasma Torch System 
Treatment of chronic foot and leg ulcers was shown to be possible using a microwave 
argon plasma torch which is, as above, rapidly cooled by fast gas flow (Figure 4) [104, 
105]. Argon is passed at 3 slpm through a 135 mm tube with six aluminum electrodes to 
which 2.45 GHz microwave power is allied. This torch operates at roughly 100 Watt [105]. 
Interestingly, the plasma afterglow generated in this way is able to sterilize many types of 
bacteria in minutes of treatment. Some of the bacteria tested were Staphylococcus 
epidermidis, Escherichia coli, Streptococcus pyogenes, Bacillus cereus, Pseudomonas 
aeruginosa, etc. Additionally Candida albicans yeast was tested. While the torch was 
effective in inactivation on all the organisms tested, the dose requirements and the size of 
the inactivation area varied by organism [104]. 
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Figure 4. Microwave plasma torch schematic (left) and plasma output photo (right) [105]. 
Figure 5 shows an example of the results of a 2 minute treatment of bacteria. An 
inactivation circle is clearly visible and is much larger than the diameter of the nozzle. 
Similar effects are observed on other types of bacteria as well [104, 105]. While the effect 
on bacteria is quite evident, Morfill et al. do not observe any effect on human blood or skin 
tissue (Figure 6) [104]. Histological evaluation of the treated tissue revealed no or little 
difference as compared with untreated skin. Only after 10 minutes of treatment 
vacuolization of keratinocytes of the basal epidermis becomes evident; curiously, these 
effects are observed in vitro on dead skin, only minutes following removal from live 
patient [104]. In any case, no effect is observed on blood or tissue in 2 minutes of 
treatment which is quite sufficient to significantly reduce bacterial load. 
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Figure 5. Bacterial cultures on agar plates after 2 minutes of plasma treatment. Left: methicillin-
resistant Staphyolococcus aureus (gram positive) Right: Burkholderia cepacia (gram negative) [104]. 
 
Figure 6. Histological images of skin samples, treated ex-vivo. After 2 minutes no changes could be 
observed with respect to the untreated control sample. Vacuolization of keratinocytes can be observed 
after 10 minutes [104]. 
 
1.4. Review Summary of Non-Equilibrium Plasma Applications in Medicine 
The above review of current applications of non-equilibrium plasmas in medicine, as our 
recent more detailed review [26], clearly demonstrates limitations of indirect application of 
plasma. Thermal plasma afterglow is mainly affecting tissues and cells through 
temperature-related effects while non-thermal plasmas are limited in their effectiveness 
when applied indirectly. Plasma was not, prior to this work, been put in direct contact with 
tissue and this thesis presents such application. In the following chapters we will discuss 
this and show that non-equilibrium cold plasma can be applied directly to living tissue 
without physical or biological damage to this tissue. We will also show that such treatment 
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can lead to rapid pathogen inactivation (sterilization) on this tissue at doses far below those 
required for damage. 
   
23 
CHAPTER 2. DEVICE FOR DIRECT NON-DAMAGING 
APPLICATION OF PLASMA TO LIVING TISSUE: FLOATING 
ELECTRODE DIELECTRIC BARRIER DISCHARGE (FE-DBD) 
 
As can be seen from Chapter 1, there is a clear need for less damaging plasma systems. 
Safety, however, becomes a very important issue when the treatment target is alive. The 
device needs to, most importantly, not kill the patient immediately. This is discussed in 
Section 2.1 where we show that in the case of the FE-DBD plasma all the power is 
deposited in the discharge and does not penetrate into the tissue. Additional safety in case 
of FE-DBD is maintained by limiting current to below 5 mA which is considered to be safe 
by the U.S. Occupational Safety and Health Administration (OSHA) [106]. 
Once the device is electrically (physically) safe, a more subtle question arises of how to 
apply this plasma in the most efficient way. Various electrode configurations are discussed 
in Section 2.2 and the power supplies in 2.3. Importance of using different plasma 
electrodes is clear: an electrode to stop micro-capillary bleeding during brain surgery 
should be quite different from a catheter-like electrode to be used during 
gastroenterological surgery. What is not immediately obvious is the need for different 
plasma power supplies or the frequency, peak voltage, polarity, and waveform at which 
they operate – this will be discussed in more detail in Section 2.3. 
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2.1. Principle of Operation of the Floating Electrode Dielectric Barrier Discharge. 
Principal of operation of FE-DBD plasma can be explained with the help of a relatively 
simple model. Let us model the insulated electrode as a sphere of diameter elD , while the 
object whose surface is being treated is modeled as a sphere of diameter obD . In the 
absence of the object the electrode capacitance with respect to the far away (located at 
infinity) ground is given by the well-known formula elel DC 02  (where 0  is 
permittivity of free space). Now, if the object being treated has a relatively high dielectric 
constant (like that of water), it effectively expels most of the electric field from its interior 
when it is brought close to the electrode. From that point of view this object behaves like a 
good conductor and, therefore, its capacitance with respect to the far away ground can also 
be modeled by obog DC 02 . The region between the object and the electrode can be 
modeled roughly as a parallel plate capacitor with the value 
g
DC elgap 2
2
0  (where g is gap 
distance) if the gap is significantly smaller than the electrode diameter. Note that 
ob
el
og
gap
gD
D
C
C
4
2
  is significantly smaller than 1 for the typical choices of characteristic sizes. 
In the absence of any conduction current, the electrical models of the electrode by itself, 
and the electrode near the treated object are well approximated by the circuits in Figure 7 
a) and b). When the electrode is well removed from the ground, the magnitude of the 
applied voltage V is insufficient to create electric field strong enough to cause the 
breakdown and discharge. However, when the object with a high dielectric constant is 
sufficiently close to the electrode, most of the applied voltage appears across the gap. This 
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is because the capacitance of the object with respect to ground is much larger than the gap 
capacitance, and the voltage divides across these capacitors proportionally to the inverse of 
their size. This results in a strong electric field in the gap which can now lead to 
breakdown and discharge. 
The electrical circuit model can be further refined by taking into account non-linear 
resistance and capacitance of the plasma created in the gap. The resulting circuit 
refinement is shown in Figure 7 c). The refined circuit does not change the main 
conclusion that most of the applied voltage appears across the plasma gap. 
 
Figure 7. Simplified electrical schematic of a) electrode itself, b) electrode near the treated object, and 
c) plasma discharge on the treated object. 
At about 10 kHz, the following circuit parameters typical for our experiments can be 
estimated assuming that body diameter is roughly 1 meter, the electrode diameter is about 
25 mm, and the gap is about 1 mm.  
pF 4104
4
120
2
  F
g
DC elgap
  
 M 2.41
gapC
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Electrical safety of the object being treated by plasma is ensured because current the power 
supply delivers is under 5 mA. Although such currents may cause some mild discomfort, 
they do not cause muscle or cardiovascular malfunction in a human and, therefore, are 
deemed safe by the U.S. Occupational Safety and Health Administration (OSHA; see [106] 
for example). 
 
2.2. Application of FE-DBD Plasma to Biological Objects 
FE-DBD system is based on a conventional dielectric barrier discharge and is basically a 
system driven by alternating current high voltage applied between two conductors where 
one or both are covered with a dielectric to limit the current and to prevent transition to an 
arc. In this setup, amplitude and waveform of the high voltage signal are quite important 
(this will be discussed in the next section). 
A simplified schematic of the treatment setup is shown in Figure 8. Here, the signal of any 
frequency, amplitude, and waveform is current-amplified and then voltage is stepped up in 
the transformer which is then connected to the “powered electrode”. The electrode is, 
basically, a conductor covered by a dielectric. Plasma is then generated between the 
surface of the dielectric and the treatment target. 
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Figure 8. General schematic of the plasma treatment experimental setup. 
The distance between electrodes plays one of the key roles in generation of plasma and 
thus for repeatable experimental results the distance needs to be precisely controlled. To 
accomplish this we simply connect the round electrode to a stage that can move in Z 
direction (up/down). This allows for one to repeatably measure and fix the distance 
between the substrate and the electrode. Figure 9 shows a schematic of such a setup where 
the electrode can be held by a “jacket” providing for the possibility of a controlled 
atmosphere (use of different gases or vacuum suction); insertion or removal of a grounded 
mesh which can separate plasma from the treatment target (which will be discussed in 
Chapter 4); insertion of, for example MgF2 or quartz glass which will allow only 
ultraviolet photons but not the rest of plasma through; and/or other additions. 
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Figure 9. Principal schematic of the FE-DBD treatment setup with removable meshes and windows. In 
this setup either agar with bacteria (shown), cell culture, or living tissue can be treated. 
 
2.3. Observation of the FE-DBD Plasma 
When the system is operating, plasma can be clearly seen by an observer, should they look 
between the electrodes. Figure 10 shows one of such situations where photographs are 
taken at different exposure times (camera shutter is left open for 1, 2, 3, 5, 10, and 30 
seconds while all other parameters are kept constant). Here plasma over the water surface 
is shown; tap water is used as it is conductive and it is grounded on the bottom. 
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Figure 10. Side view of plasma over the surface of water at different exposure times. 
More interesting is the observation of plasma as the treatment target sees it. Figure 11 
shows a setup where water is used as the powered electrode. Water is clear, so plasma can 
be observed directly but dielectric heating effects at our operating frequencies [107, 108] 
create the need for cooling which is accomplished by flowing water through the electrode 
and into the ice bath. It is important to note that degasifying water improves visibility 
through the electrode as does using distilled water with NaCl addition to desired 
conductivity. 
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Figure 11. Water electrode setup schematic. 
This setup allows for many different types of observations. For example, Figure 12 shows 
one such observation where medical-grade dry air is flown from a gas tank at 3 slpm 
through sinusoidal excitation wave discharge. Interestingly, even though plasma is 
instantaneously (1/250 sec) quite non-uniform, filaments cover practically the entire area 
after less than 0.2 seconds. 
 
Figure 12. 0.004 sec (left) and 0.2 sec (right) exposures of the FE-DBD plasma in dry air (from gas 
tank) at 3 slpm flow rate with sinusoidal excitation wave. 
Of note about Figure 12 is that we observe microfilament movement. These filaments are 
approximately 0.1 mm in diameter and at these flow rates we should see them as stationary 
dots. Calculating the distance the filament traveled in 1/250 sec and comparing it with 
approximate flow velocity we find that they are comparable [109]. Further research is 
being performed on this subject currently (see [110] for initial results and discussion). 
  
31 
CHAPTER 3. DIRECT NON-EQUILIBRIUM PLASMA 
APPLICATION FOR SKIN STERILIZATION; EFFECTIVENESS OF 
DIRECT VERSUS INDIRECT (JET) PLASMA TREATMENT 
3.1. Quantitative Direct Sterilization on Agar 
Careful sample preparation is required before carrying out the plasma experiments. Since 
our interest is primarily in sterilization of skin of an animal or human, bacterial samples 
were collected from de-identified skin samples from human cadavers at the Hahnemann 
Hospital (Philadelphia, PA). Identification of the bacterial species was performed using 
standard methodology at the Hahnemann Hospital’s Clinical Microbiology Labs. Bacteria 
from skin samples consisted of staphylococci, streptococci, and Candida species of yeast. 
To collect these micro-organisms, six skin samples were swabbed twice each by sterile 
cotton-tipped applicators pre-wetted with 10X Phosphate Buffered Saline (PBS). These 
applicators were then transferred into 5 mL of 10X PBS and placed into an ultrasonic bath 
for 10 minutes to lift off the bacteria from the swab. The resulting solution was transferred 
onto the blood agar plate (Trypticase™ Soy Agar with 5% Sheep Blood) and incubated in 
air at 37 °C for 24 hours. The resulting colonies were collected and re-inoculated onto 
fresh blood agar plates and again incubated for 24 hours. These steps were repeated to 
obtain large quantities of bacteria. In the end of this preparation, bacteria were collected 
from the plates and diluted in 10X PBS to approximately 109 colony forming units (CFU) 
per mL. Bacterial concentration was assessed by a standard dilution assay [111, 112]. 
Since the results of the plasma treatment are characterized below in terms of appearance of 
the blood agar surface after the treatment, it is important to normalize the results by 
establishing how the agar surface would look for different concentrations of colony 
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forming units (CFUs) on its surface. To do that we exposed an agar-covered Petri dish with 
bacteria cultured on its surface from samples prepared as described above to the DBD 
plasma for different times at fixed plasma power levels [19]. The exact plasma set-up, 
surface power density, and other plasma parameters used for these normalization 
experiments are the same as those used in the experiments described later that compare 
direct and indirect treatment. 
To quantify sterilization efficiency, 20 μL drops of 109 cfu/mL bacteria were placed on 
agar surface, left to dry for 5 minutes, and finally treated by plasma. This volume was 
selected as it spread to ~1 cm2 over the agar surface; thus, the area covered by the bacterial 
sample drop was entirely within the area covered by the insulated plasma electrode. 
Following the treatment the drop was spread over the entire agar surface and incubated in 
air at 37 °C for 24 hours. Bacterial colonies (CFUs) were then counted and the results are 
presented in Table 3. There is a clearly visible difference in agar appearance between 
untreated, partially sterilized, and completely sterilized agar. Based on this difference, it is 
reasonable to classify the appearance of the bacterial surface into 5 categories: 1) untreated 
(109 cfu/mL), 2) partially disinfected (109 to 107 cfu/mL) 3) disinfected (107 to 104 
cfu/mL), 4) partially sterilized (1,000 to 10 cfu/mL), and 5) completely sterilized (zero 
cfu/mL). Note that the definitions of sterilization and disinfection follow those that are 
accepted in the literature [19, 43, 51, 103, 113-115]. 
Table 3. Bacteria sterilization results (in cfu/mL) 
Original 
Concentration 
5 sec of 
FE-DBD 
10 sec of 
FE-DBD 
15 sec of 
FE-DBD 
109 850 ±183 9 ±3 4 ±4 
33 
108 22 ±5 5 ±5 0 ±0 
107 6 ±6 0 ±0 0 ±0 
 
To quantify the extent of sterilization, 1 mL of 109 cfu/mL was poured over the entire agar 
surface. These samples were left to dry for 3 hours and then treated by plasma. Here 
plasma only covered a portion of the Petri dish. Following the 24 hour incubation period, 
the extent of sterilization was clearly visible – areas where bacteria were killed looked like 
uncontaminated agar while areas that received no treatment changed color and appearance 
significantly as bacteria grew there. The complete sterilization area is easiest to identify – 
it corresponds to the agar area that is completely clear from bacteria (for examples, see 
Figure 13 or [19]). Partial sterilization is also relatively easy to define since the number of 
CFUs is relatively small and can be counted. Disinfection is more difficult to assess 
because of the difficulty of counting the large number of CFUs. As can be seen from 
Figure 13, the complete sterilization gradually fades into untreated areas, forming a “grey-
scale” fade that gradually increases from 0 cfu/mL in the sterile zone to 109 cfu/mL in the 
untreated zone much like in the quantitative experiments described in the previous 
paragraph. 
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Figure 13. Photograph of the blood agar Petri dish following 24 hour incubation period of bacterial 
sample treated by FE-DBD plasma for 10 seconds: plasma-agar contact area is completely clean of 
bacterial colonies, area outside of plasma shows partial inactivation, and the rest of the Petri dish 
shows complete coverage with bacterial colonies. 
 
3.2. Comparison of Direct and Indirect Sterilization in Open Air 
Over the past few years new non-thermal atmospheric pressure plasma (APP) devices have 
emerged with several important applications in medicine. These applications involve 
possibly-selective inactivation of unhealthy cells [5, 12, 17, 19, 113, 116-118], blood 
coagulation [3, 5, 19, 119], and killing of parasites, bacteria, fungi and viruses on living 
tissue [8, 16, 17, 19, 48, 115, 120-128]. Another attractive application is sterilization of 
various surfaces [17, 43, 44, 103, 113, 115, 120, 129-131]. Two different approaches have 
been suggested for atmospheric pressure non-thermal plasma-based sterilization of living 
tissues. These two approaches can be classified as indirect and direct. Indirect treatment 
uses a jet of products (plasma afterglow) generated in remotely located plasma discharge. 
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Direct treatment, by contrast, uses the tissue itself as an electrode that participates in 
creating the plasma discharge, as illustrated below. Plasma in this case is contained 
between the quartz surface of the powered high voltage electrode and the surface of 
bacteria or tissue being treated. It is important to stress that the distinction between these 
two approaches is not only related to the proximity of the plasma and the tissue, but that 
direct contact with plasma brings charged energetic particles to the plasma-tissue 
interface. By contrast, no charged particles are usually taken out of the plasma region by a 
jet even if the plasma region is located only a fraction of a millimeter away. The question 
arises: Is there a substantial difference between the two types of treatment? In other words, 
is the transport of charged particles to the surface being treated as important or is the effect 
of plasma due mainly to long-living active molecules and longer wavelength ultraviolet 
radiation (as short wavelength “vacuum” UV is absorbed by air at atmospheric pressure 
within microns) [43, 132-135]. 
Here we compare effectiveness of direct and indirect sterilization treatment by non-thermal 
APP generated using the same discharge setup, and demonstrate that the direct treatment 
can achieve sterilization much faster without any thermal effects. Specifically, we employ 
the same Dielectric Barrier Discharge (DBD) to compare both types of treatment. To do 
that, we carried out two types of experiments. In one set of experiments we employed a 
surface covered by bacteria as a DBD electrode, placed a second smaller area DBD 
electrode over it and compared the areas of sterilization with air flow parallel to the surface 
and without the air flow. In another set of experiments we again employed a surface 
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covered by bacteria as one DBD electrode and compared the rate of sterilization to the case 
when this surface was separated from the DBD discharge by a grounded mesh electrode. 
Here we attempt to compare direct and indirect application of plasma for sterilization. 
Since we are comparing two different modalities to each other, difference between them 
needs to be kept to a bare minimum. The basic idea is to somehow separate the effect of 
direct plasma from indirect effect of plasma afterglow. We achieve this in two setups: 1) 
we separate plasma from bacteria by a grounded metal mesh; and 2) we blow pair through 
plasma which is in direct contact with bacteria, thus creating a “tail” of afterglow effect. 
From the previous chapters it is clear that non-thermal plasma, specifically the Floating 
Electrode Dielectric Barrier Discharge, is able to achieve a medically-relevant therapeutic 
effect when it is applied to living tissue. We show that FE-DBD plasma is able to sterilize 
surface from bacteria while causing no visible or microscopic damage to this surface. A 
question then arises: What in plasma could potentially be responsible for sterilization and 
how does the effect of FE-DBD compare to application of other types of plasmas? 
Different cold plasmas also show therapeutic effect, see for example Dr. Stoffels’ et al 
“plasma needle” [18, 97, 98, 118, 136-138], Dr. Laroussi’s et al “plasma plume” (or 
“plasma pencil”) [2, 25, 42, 44, 47, 139], or Dr. Coulombe’s et al “atmospheric pressure 
glow discharge torch (APGD-t)” [12, 14, 140-142], etc. 
There are two modes of application of FE-DBD to the surface being treated: 1) where the 
tissue or cells are used as a second active electrode – plasma then is bound between the 
dielectric surface of the powered electrode and the surface of the tissue being treated; or 2) 
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where plasma is separated from the tissue by a grounded metal mesh and gas is blown 
through the discharge to carry active species outside of the plasma. We call the first 
method a “direct” and the second an “indirect” application of plasma to tissue. It was 
previously shown that direct application of plasma yields to roughly a two orders of 
magnitude improvement in rate of bacteria inactivation as compared to indirect application, 
even when the plasma is removed from tissue only a fraction of a millimeter away [27]. 
Effects of direct application of dielectric barrier discharges in air to bacteria can be 
separated into four major categories: 
1. Effects of Ultraviolet (UV) radiation. In addition to the longer wavelength UV 
(180-340 nm) we also need to account for contribution of deeper UV, or Vacuum 
UV1 (110-180 nm) as the plasma is in direct contact with tissue. 
2. Global effects of increased gas temperature in the discharge gap and of the applied 
electric field (field of the electrodes, not the self-generated field gradients at the 
streamer head). 
3. Effect of neutral active species generated in plasma; for example the long-living 
ozone, NO, HO2, etc, or the short-living OH, atomic oxygen, electronically excited 
oxygen O(1D), O2(1Δg), etc. 
4. Effects of charged species: electrons and positive and negative ions. 
                                                 
1 VUV is absorbed in air in microns and thus cannot travel outside of the discharge zone, 
however in the direct plasma treatment this plasma is in direct contact with tissue and thus 
if the more energetic VUV photons are generated they can, in fact, reach the treatment 
target. 
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Below, we will show that all the effects of direct plasma on bacteria are negligible 
compared to the effects of charges. In short, leaving only UV radiation (removing plasma 
by use of quartz (UV) or magnesium fluoride (VUV) windows) removes the ability of 
plasma to sterilize. Global gas temperature and applied electric fields are also negligible as 
the gas temperature rise is insufficient to achieve sterilization and the frequency and 
waveform utilized is out of the range for effective electroporation (see [26, 27, 143-146] 
for further details). Effects of neutral active species cannot be ignored. Neutrals by 
themselves, given enough time, are able to sterilize as well as direct plasma treatment and 
they are also responsible for many interesting biological effects; i.e. effect of NO in tissue 
regeneration [21, 26, 76]. 
 
3.2.1. Direct and Indirect Plasma Setup Employing Mesh to Separate the Effect 
For the first setup we employ what we call a “spider” electrode (Figure 14). The electrode 
itself in this setup is the same as described above; however, it is covered with a “jacket” 
which can be grounded and into which we can insert spacers to precisely control distance. 
The jacket is supplied with gas feed lines to allow for controlled atmosphere. 
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Figure 14. A 3-dimentioan representation and schematic of the electrode with controlled atmosphere. 
Illustrated in Figure 15 is such an electrode in use. During the treatment the entire setup, 
including bacteria-covered agar, is placed upside down so the agar is in full contact with 
the jacket and is kept down by its own weight. The electrode footprint can be clearly seen 
on agar post-incubation (Figure 15) where gas output channels are visible. 
 
Figure 15. Schematic of treatment of bacteria on blood agar and the electrode footprint generated by 
this method. 
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In this setup, when plasma is turned on, we get essentially the same FE-DBD system 
described above and shown schematically below in Figure 16. Let us call this setup 
“direct” treatment as plasma is clearly in direct contact with bacteria. The step on the metal 
jacket is 0.5 mm and the spacer is 1.5 mm tall. Thus, the distance between bacteria and 
quartz is 2 mm. We can also place a grounded metal mesh between the perforated spacer 
and the step on the metal jacket as is shown in Figure 17. If we then replace the 1.5 mm 
spacer with a 2 mm spacer we get two setups which generate nearly identical plasmas 
(with the exception of bacteria at the boundary in the first case and metal mesh in the 
second, but this difference cannot be avoided in this setup and will be addresses below). 
We call this an indirect treatment as plasma is separated from bacteria by the mesh. We 
can now flow gas through this setup. In the case of the first setup this does not much alter 
plasma, but in the case of the second one longer-living active species and radicals are 
carried out of plasma while charged species (electrons and ions) are captured by the mesh. 
 
Figure 16. Schematic of the direct/indirect treatment setup in the “direct” mode without the grounded 
mesh: plasma contacts bacteria directly. 
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Figure 17. Schematic of the direct/indirect treatment setup in the “indirect” mode with the grounded 
mesh: plasma is bound by the mesh and only the plasma afterglow can reach the surface of bacteria. 
 
3.2.2. Direct and Indirect Plasma Setup Employing Gas Flow (Blower) to Separate the 
Effect 
Even though the setup presented above is able to show us clear difference between direct 
and indirect application of plasma, one could argue that the plasma characteristics are 
changed by introducing a metal mesh rather than moist bacteria on surface of a moist 
hydrogel. For this reason and to compare the results we have introduced a second system 
where only direct plasma is used but we flow air through the discharge creating the plasma 
“jet” effect on the other side (Figure 18 and Figure 19). The setup is the same as above but 
we have removed the jacket and added a fan to move air through plasma essentially 
creating the afterglow effect on the opposite side. 
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Figure 18. Schematic of the direct/indirect treatment setup with blower used to create the indirect 
treatment effect of the plasma afterglow. 
 
Figure 19. Photograph of the setup used for direct/indirect experiment with using the blower to move 
air through plasma. 
 
3.2.3. Results of Direct and Indirect Treatment in Ambient Air 
We now describe the first of the two types of experiments that compare direct and indirect 
plasma treatments. The setup is illustrated in Figure 16 and Figure 17 and discussed above. 
To test the sterilization treatment, we used an agar-covered Petri dish with bacteria spread 
on its surface from the earlier prepared samples of 109 cfu/mL concentration. Specifically, 
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one milliliter of such bacterial sample was transferred onto the blood agar and spread over 
the entire plate. The plates were dried for 3 hours in a Class II biological safety cabinet 
(SterilchemGard™ SG-4TX, The Baker Company) prior to the plasma treatment. After the 
plasma treatment, the samples were incubated in air at 37 °C for 24 hours to assess the 
ability of the DBD plasma to sterilize. Control experiments with gas flow only were 
performed for all gas flows shown here. Bacteria were completely unaffected by flowing 
room air in up to 30 minutes (maximum time tested) as these bacteria were at a surface of a 
hydrogel (agar) which takes over 3 days to dry. When exposed to dry air, agar surface 
begins to show signs of drying, beginning at 10 minutes, but bacteria were unaffected by 
this even after 30 minutes of dry air2. 
When placed on a metal substrate, the agar dish with bacteria on its surface acts as one of 
the DBD electrodes – bacteria are at the plasma-agar interface. The other smaller area 
DBD electrode is made of 2.5 cm diameter solid copper disc separated from the plasma by 
a 1 mm thick quartz dielectric. The plasma gap, or the distance between quartz-plasma and 
agar-plasma interfaces was set to 1.5 mm. Alternating polarity sinusoidal voltage of 35 kV 
magnitude (peak to peak) and 12 kHz frequency was applied between the copper electrode 
and the aluminum substrate under the agar Petri dish. A standard 120 mm high speed fan 
(Multicomp MC1122HBT, 120x120x25 mm, 40 slps) was placed ~20 cm away from the 
discharge and the angle of the fan was adjusted to allow for maximum air flow parallel to 
the substrate through the plasma gap. Flow speed for this experiment was measured 
                                                 
2 Also of note is that the humidity in the incubator is maintained at >80% so if the agar 
dries outside, once placed in the incubator, bacteria get all the moisture and nutrients 
necessary for their proliferation. 
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between the electrode and the substrate, directly outside of the electrode, to be 0.8 ±0.3 m/s 
(EXTECH Instruments model 407123 Hot Wire Thermo-Anemometer) (see Figure 18 and 
Figure 19). 
The power surface density delivered into the plasma discharge was measured by two 
methods. One was the more traditional electrical measurement method involving voltage 
across the discharge and current into it. This measurement was performed using a high 
speed high voltage probe (PVM-4 1000:1, North Star High Voltage, Marana, AZ) and high 
speed current probe (1 V/Amp +1/-0% sensitivity, 10 ns usable rise time, 35 MHz 
bandwidth, Model 4100 Current Monitor, Pearson Electronics, Palo Alto, CA). Signals 
from the probes were measured and integrated using a high speed oscilloscope (500 MHz 
bandwidth, 5x109 samples/s, TDS5052B, Tektronix, Inc, Richardson, TX). These electrical 
measurements were confirmed using custom-built calorimetric measurement set-up. Both 
electrical and calorimetric measurements indicated the power of 0.8 ±0.2 W/cm2. 
When there is no air flow parallel to the surface, the area directly under the second smaller 
electrode is exposed simultaneously to charged particles, UV, and the plasma afterglow 
containing longer living active plasma components such as ozone (O3), nitric oxide (NO), 
hydroxyl radicals (OH), and other excited molecular and atomic species. In the presence of 
the airflow, the area under the second smaller electrode experiences practically the same 
conditions as without the flow. However, in the presence of flow the plasma afterglow will 
also impinge on the areas of the substrate that are not directly under the second smaller 
electrode as it is illustrated in Figure 18. 
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It should be stressed that, even in the absence of any flow, the sterilization region is not 
confined to the diameter of the copper electrode. With increasing treatment time, this 
region extends several millimeters outside the electrode [20, 27]. There are two reasons for 
this: first, due to the existence of surface discharge near the base of DBD filaments, the 
“footprint” of a micro-channel is substantially larger than its diameter [19, 147]. Second, 
since the field lines originating near the edge of the insulated electrode tend to spread out 
slightly, the discharge filaments also spread out beyond the area of the top electrode. The 
flow, however, is not expected to change the shape of the plasma discharge region because 
it is not capable of moving the filaments further than a fraction of a millimeter, as was 
observed with high speed photography (not shown) as well as theoretically [147, 148]. 
However, such effects are expected to be confined to within millimeters from the edge of 
the copper electrode, while the longer living active species and radicals can spread much 
further with gas flow [43, 97, 103, 147-149]. 
The results comparing the sterilization with and without flow are illustrated in Figure 20 
and zoomed in version in Figure 21. As can be seen from these figures, complete 
sterilization by direct plasma treatment under the insulated electrode is achieved in 15 
seconds. If air is passed parallel to the substrate through the plasma region, the disinfection 
area shifts by several millimeters, but a “tail” of disinfection appears. Even though 
complete sterilization is not observed in this “tail”, different degrees of disinfection are 
evident. Locations closer to the plasma region have greater degree of disinfection. This 
suggests that plasma “afterglow”, or the gas carried through and outside of plasma, does 
contain active species and radicals that have bactericidal effects, although direct plasma is 
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substantially more potent as a sterilizing agent. Complete sterilization, however, did not 
extend to the region reachable by the plasma afterglow in as much as 5 minutes of 
treatment. This clearly demonstrates that longer living active species generated in plasma 
are much less effective than direct plasma where charged particles participate in the 
process. 
 
Figure 20. Using a blower to shift sterilization region does not affect plasma and shows little effect of 
the afterglow: 15 seconds of treatment with (a) blower off and (b) blower on (air flows up). Note: 
arrow is painted on the back of the dish and shows through on the photograph. 
 
Figure 21. Zoomed in photograph of the bacterial growth results following plasma treatment and 
incubation (photograph is converted to black and white for increased contrast). Note: arrow is painted 
on the back of the dish and shows through on the photograph. 
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In the first type of experiments described above, effects of plasma “afterglow” were 
separated from the effects of charged particles and from the UV radiation. In the second 
type of experiments described below, plasma afterglow together with UV is compared 
against the direct plasma, involving also charged particles. The direct treatment is obtained 
similarly to the first type of experiments described above. However, instead of creating 
airflow parallel to the substrate, provisions were made to allow introduction of air at 
different flow rates into the discharge gap (see Figure 16 and Figure 17). To obtain indirect 
treatment including UV effects, agar surface covered by bacteria was again employed as 
one DBD electrode; however, this surface was separated from the DBD discharge by a 
mesh electrode, as illustrated in Figure 17. With a grounded mesh in place, bacteria are no 
longer at the plasma interface, as plasma is bound between the grounded mesh and the 
quartz-covered electrode. The mesh (22.04 wires per cm, 0.1016 mm wire diameter, 0.351 
mm opening, 60% open area, weaved mesh) is placed 1 mm above the surface of the agar, 
which permits only the passage of ultraviolet radiation and longer wavelength photons (not 
vacuum UV), gas, radicals and other longer living particles created in the plasma gap 
between the mesh and the quartz-insulated electrode above it. The second electrode used 
with the mesh was the same electrode that was employed in the direct treatment setup 
illustrated Figure 16. The gap between the mesh and the second electrode is set at 1.5 mm, 
just as in the plasma gap of the direct treatment setup. The setup used to introduce air into 
the discharge gap at 3 different flow rates (1, 5, and 10 slpm, corresponding to flow speeds 
of 0.078, 0.393, and 0.853 m/s through the mesh) is illustrated in Figure 17. The air was 
introduced into the discharge gap to enhance extraction of the plasma afterglow through 
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the mesh. In both direct (without the mesh) and indirect (with the mesh) situations the 
same air flow rates were employed and the discharge was calibrated to the same plasma 
power for both cases. 
To ensure that both setups, with and without the mesh, produce the same UV radiation, we 
correct for the UV transparency of the mesh using separate measurements. Regular paper is 
placed over the light source in these measurements to diffuse the light and a spectrum is 
measured using TriVista Spectrometer System with Princeton Instruments PIMAX 
intensified CCD camera with only paper, and with paper and mesh. It turns out that the 
mesh cuts off roughly ~40% of visible light and ~20-40% of UV light depending on the 
wavelength of UV (Figure 22 – graph in visible light range and Figure 23 – measurements 
in ultraviolet range). 
 
Figure 22. Results of measurement of light intensity in the visible spectrum for no mesh, fine mesh, and 
coarse mesh. 
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Figure 23. Results of measurement of light intensity in the ultraviolet spectrum measured at three 
peaks (239.5 nm, 263.54 nm, and 284.03 nm) without mesh (taken as 100%) and with mesh. 
The results comparing direct (without the mesh) and indirect (with the mesh) sterilization 
are illustrated in Figure 24. It is clearly visible that plasma that comes in direct contact 
with bacteria is able to sterilize significantly faster than afterglow or jet. Only 5 seconds of 
direct plasma treatment results in the appearance of inactication region (spot near the 
center). Complete sterilization occurs within 15 seconds when direct treatment is employed 
and only partial disinfection can be achieved within the same time frame with indirect 
treatment. Over 5 minutes of indirect treatment is required to achieve sterilization results 
similar to direct treatment obtained within 15 seconds. Therefore, even with substantial 
UV radiation, indirect plasma treatment is significantly weaker than direct plasma which 
includes bactericidal effects due to charged particles. 
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Figure 24. Direct application of plasma yields to better sterilization efficiency than treatment by 
plasma afterglow: (a) 5 seconds and (b) 15 seconds of direct plasma compared with (c) 30 seconds and 
(d) 2 minutes of plasma jet. 
 
3.3. Effects of UV Radiation, Applied Electric Field, Thermal Energy, and Other 
Indirect Plasma Effects 
Several possibilities exist that might explain why bacteria inactivation, disruption of 
membrane’s normal functions, or disruption of normal metabolism functions occurs only 
in the presence of the DBD discharge. One possibility is that UV radiation (probably in the 
UV-C band) works in synergy with chemically active species produced by direct plasma in 
the liquid surrounding the organisms to break the integrity of cellular membranes (Figure 
25 – emission spectra from plasma in UV range). Photon energy of the UV-C radiation 
(about 4-6 eV) is sufficient to break some chemical bonds in bio-molecules [150]. More 
energetic VUV-photons, however, are unable to penetrate deep through the layer of liquid 
and through bacterial membrane [151-153]. The UV-C radiation can be effectively 
delivered to the membrane, but its energy can be sufficient also for structural 
reorganization of the bio-molecules (including fatal but slow DNA changes), and 
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disruption of hydrogen bonds responsible for the integrity of the membrane’s lipid bi-layer. 
Such disruption of the lipid bi-layer may open the membrane to penetration of multiple 
active plasma species, particularly such strong oxidants as atomic oxygen, peroxide 
radicals, singlet oxygen, NO, and positive ions [24]. Thus, deep penetration of the strong 
plasma treatment effect can possibly be attributed to synergy of UV-C radiation with 
plasma-generated active chemical oxidants. 
 
Figure 25. Emission from DBD plasma over the cell surface in UV range. 
Although the UV and highly energetic VUV radiation have been linked to efficient cell 
inactivation rates [132, 154, 155] we show that this effect is negligible in sterilization of 
bacteria. We are able to separate effects of UV by inserting a quartz slide between the 
bacteria and plasma, and effects of VUV by use of magnesium fluoride (MgF2) slide. 
Quartz is transparent to UV photons of >200 nm wavelengths and MgF2 is transparent to 
VUV photons of >140 nm wavelengths [152]. This way only UV/VUV photons generated 
in plasma reach bacteria. Even though we observe no visible effect on bacteria by 
UV/VUV photons (Figure 26), it cannot be discounted completely as UV, especially VUV, 
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is known for its synergetic effect in interaction and destruction of model polymers [151-
153]. 
 
Figure 26. No effect on bacteria protected from plasma by MgF2 slide (10 mm square in the center) is 
observed. 
When grounded mesh is placed directly onto agar, an interesting (but expected) pattern 
emerges where only the areas in the openings of the mesh are sterilized and not under the 
mesh itself (Figure 27). This is indicative that the bacteria are protected by the mesh – 
whatever is produced in plasma and is possibly embedded/diffused into the agar does not 
exit the areas that were originally open. The wire diameter in the woven mesh on Figure 27 
is ~150 μm and the opening width is ~240-300 μm – if something was diffusing or 
penetrating under the wires or under the open areas in the weave pattern one should be also 
to see it more clearly than what is seen in the photo. 
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Figure 27. Grounded mesh placed directly on bacteria (no space) generates interesting pattern: only 
mesh openings are sterilized (magnified area is color-corrected for clarity). 
High electric  fields, especially pulsed electric fields are known to  inactivate bacteria 
in  solution  ሾ64,  156‐158ሿ.  The  field  strength  required  for  this,  however,  is  on  the 
order  of  a megavolt  per  centimeter  –  significantly  higher  than  the  applied  electric 
field we are  employing which  is  on  the order of 10  to 30 kV. Experimentally,  if we 
apply  electric  field  at  the  strength  just  below  the  breakdown potential we  observe 
absolutely  no  effect  on  bacteria  as  the  agar  looks  complete  unaffected  by  this 
following 24 hour incubation. We cannot, however, completely discount the effect of 
the  electric  field.  In  the  head  of  a  developing  streamer,  the  electric  field  are much 
higher and can be estimated to be: 
ܧ௠ ൌ ܧ଴ · ቆ3 ൅ ൬݈ݎ൰
଴.ଽଶ
ቇ ൌ 2.6 · 10଺ V/cm 
where ܧ௠ is the field at the head of a needle‐streamer of length ݈ ሺ0.2 cmሻ and radius 
ݎ ሺ0.1 cmሻ at the applied field ܧ଴ of 35 kV. Field needed to destroy a chemical bond is 
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on  the  order  of  3V/3Åൎ108  V/cm;  to  break  a  Hydrogen  bond  ൎ107  V/cm;  and  to 
break Van der Waals bond ൎ106 V/cm. It is also known that ~1 Volt applied across a 
cell membrane ሺ~ 3 nm thickሻ is able to depolarize and break it ሾ156, 159‐161ሿ. Field 
needed for this is 1V/3nmൌ3ڄ106 V/cm. Thus, electric field at the head of streamer as 
it reaches the bacteria surface is sufficient to open the membrane and thus potentially 
lead  to  leakage  of  cellular  contents  out  and  various  substances  detrimental  to  the 
organism into the cell. 
 
3.4. Direct and Indirect Plasma Treatment in Various Gases 
Additional  experiments  were  performed  to  analyze  behavior  of  plasma  and  its 
sterilization  ability  in  different  gases.  Five  areas  were  observed  following  the 
treatment:  (1)  right under the electrode, (2) outside of the electrode but inside of the 
treatment area bound by legs, (3) inside of the gas channel, (4) immediately outside of the 
gas channel, and (5) outer parts of the dish not in the direct gas path (Figure 28). Effect of 
treatment was observed following the 24-hour incubation and rated from 0 (no visible 
effect) to 5 (complete sterilization). For example, Petri dish in Figure 28 would be rated as 
1-2 (visible disinfection in area right under the electrode), 2-1, 3-1, 4-1, and 5-0. Detailed 
results for various gases are presented in Table 4. Dry gas was obtained from the cylinder 
or bubbled through sterile deionized water to increase humidity. Humidity was measured 
to 80% when air was used (both for 1, 3, and 10 slpm flow rates) and not measured for 
other gases. Basic conclusion of this study is that oxygen is required for fast and effective 
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inactivation of bacteria and inactivation rate depends little on the exact gas composition, 
purity (determined by gas flow rate and, of course, the grade used), or humidity. 
 
 
Figure 28. Identification of different areas under the FE-DBD electrode following the plasma 
treatment and 24-hour incubation: (1) under the electrode, (2) outside of the electrode but inside of the 
treatment area bound by legs, (3) inside of the gas channel, (4) immediately outside of the gas channel, 
and (5) outer parts of the dish not in the direct gas path. 
 
Table 4. Results of treatment of bacteria by FE-DBD plasma in different gases. Areas of treatment are 
identified in Figure 28. Note: all experiments are repeated in triplicate and the results presented here 
are averaged. 
Dry  Gas  Time  Flow  Area 
or Wet     (sec)  (slpm)  1  2  3  4  5 
Dry  air  5  1  1  1  0  0  0 
Dry  air  10  1  2  1  1  0  0 
Dry  air  30  1  5  1  2  1  0 
Dry  Ar  5  1  0  0  0  0  0 
Dry  Ar  10  1  1  0  0  0  0 
Dry  Ar  30  1  1  0  0  0  0 
Dry  He  5  1  0  0  0  0  0 
Dry  He  10  1  1  0  0  0  0 
Dry  Gas  Time  Flow  Area 
or Wet     (sec)  (slpm)  1  2  3  4  5 
Dry  N2  5  10  1  0  0  0  0 
Dry  N2  10  10  1  0  0  0  0 
Dry  N2  30  10  1  0  0  0  0 
Dry  N2‐NO  5  10  1  0  0  0  0 
Dry  N2‐NO  10  10  1  0  0  0  0 
Dry  N2‐NO  30  10  2  1  0  0  0 
Dry  O2  5  10  2  1  2  2  0 
Dry  O2  10  10  2  1  2  2  1 
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Dry  He  30  1  1  0  0  0  0 
Dry  N2  5  1  1  0  0  0  0 
Dry  N2  10  1  2  0  0  0  0 
Dry  N2  30  1  2  0  0  0  0 
Dry  N2‐NO  5  1  1  0  0  0  0 
Dry  N2‐NO  10  1  2  0  0  0  0 
Dry  N2‐NO  30  1  2  0  0  0  0 
Dry  O2  5  1  3  1  2  2  0 
Dry  O2  10  1  3  1  2  2  0 
Dry  O2  30  1  3  2  2  2  1 
Dry  air  5  10  2  1  2  2  0 
Dry  air  10  10  3  1  2  2  0 
Dry  air  30  10  3  2  2  2  0 
Dry  Ar  5  10  0  0  0  0  0 
Dry  Ar  10  10  0  0  0  0  0 
Dry  Ar  30  10  1  0  0  0  0 
Dry  He  5  10  0  0  0  0  0 
Dry  He  10  10  1  0  0  0  0 
Dry  He  30  10  1  0  0  0  0 
 
Dry  O2  30  10  3  1  3  2  1 
Wet  air  5  3  2  1  2  1  0 
Wet  air  10  3  3  1  3  2  0 
Wet  air  30  3  4  1  3  3  0 
Wet  Ar  5  3  0  0  0  0  0 
Wet  Ar  10  3  0  0  0  0  0 
Wet  Ar  30  3  1  0  0  0  0 
Wet  He  5  3  0  0  0  0  0 
Wet  He  10  3  1  0  0  0  0 
Wet  He  30  3  1  0  0  0  0 
Wet  N2  5  3  0  0  0  0  0 
Wet  N2  10  3  1  0  0  0  0 
Wet  N2  30  3  1  0  0  0  0 
Wet  N2‐NO  5  3  0  0  0  0  0 
Wet  N2‐NO  10  3  1  0  0  0  0 
Wet  N2‐NO  30  3  2  0  0  0  0 
Wet  O2  5  3  2  1  2  2  0 
Wet  O2  10  3  3  2  3  3  0 
Wet  O2  30  3  3  2  3  3  1 
 
3.5. Effect of Localized High Electric Fields and Effect of Heating 
It turns out that the way the voltage is delivered to the electrode can be quite important. 
The main issue here is the rise time of the voltage [147, 148, 162]. In dielectric barrier 
discharges at atmospheric pressure, breakdown occurs following the so-called spark 
breakdown mechanism [163, 164]. The initial electron avalanche transitions to streamer in 
approximately 20 – 60 nanoseconds (Figure 29). Thus, if the voltage is increased slowly, 
as is the case with sinusoidal excitation wave (~ 1 V/nsec), the number of streamers 
occurring during a single cycle can be quite high. Since the initial streamer forms a pre-
ionized channel, probability of the next streamer to strike in the same position is increased. 
So, in the case of a sinusoidal excitation wave, multiple streamers strike in the same 
position creating a rather energetic channel called microfilament. Among other things, 
temperature in this channel can get to quite high values (see Figure 30). To solve this, we 
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have employed pulses rather than sinusoidal wave allowing for voltage rise time of ~ 5 
V/nsec and pulse duration of a few microseconds [143, 165]. Time between pulses is 
sufficient for the gas to return to the initial conditions so that during the next pulse 
streamers again strike randomly [147, 148, 162]. Of course, decreasing the pulse duration 
even further would lead to even better conditions for surface treatment; we will discuss this 
later in this section. 
 
Figure 29. Avalanche transition to streamer [162]. 
These power supply systems operate on the basis of voltage amplification: a low voltage 
pulse or a sinusoidal wave is generated, then the current is amplified, and is finally passed 
through a transformer with high turns ratio. High voltage signal is then taken from the 
transformer’s secondary coil and collected to the load [19]. For power analysis of these 
systems (plasma in continuous sinusoidal wave or pulsed mode) we measure current 
passing through plasma and the voltage drop in the gap. For current analysis we utilized a 
magnetic core current probe (1 Volt/Ampere +1/-0% Sensitivity, 10 nanoseconds usable 
rise time, 35 MHz bandwidth, Model 4100 Pearson Current Monitor, Pearson Electronics, 
Palo Alto, CA). Voltage was measured using a wide bandwidth voltage probe (PVM-4 
1000:1, North Start High Voltage, Marana, AZ). Signals were acquired and recorded by a 
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Digital Phosphor Oscilloscope (500 MHz bandwidth, 5·109 samples/s, TDS5052B, 
Tektronix, Inc, Richardson, TX). Acquired data was then integrated in MATLAB. Due to 
the limitations of the probes, this system cannot be used to analyze the power deposited 
into nanosecond pulsed plasma. 
In general, DBD plasmas are deemed “non-thermal” as the temperature of ions is 
significantly lower than that of electrons. However, especially in more filamentary 
regimes, temperature in the filament can grow above room temperature and potentially 
damage the surface being treated, particularly in the case of sensitive surfaces like in 
polymer surface treatment or in biological applications [24, 162]. For this reason we have 
employed emission spectroscopy to measure the vibrational and rotational temperatures in 
plasma. The temperature measurements were made utilizing the 375.4 nm and 380.4 nm 
vibrational lines and the rotational structure in those regions of the second positive system 
of nitrogen. An experimentally obtained spectrum was compared to the simulated spectrum 
to obtain vibrational and rotational temperatures (this procedure has been described in 
detail previously [149, 166, 167]). A  fiber‐optic bundle (Princeton Instruments‐Acton, 
10 fibers – 200 μm core) was utilized to acquire the emission from the discharge and 
to  transmit  it  to  a  spectrometer  (Acton  Research  SpectraPro  500i  with  Roper 
Scientific  model  7430  CCD  camera)  and  spectra  were  digitally  acquired  with 
approximately  0.6  nm  resolution.  Temperature  of  the  camera  was  set  to  ‐25°C. 
Typical  acquisition  time  for  the  spectra  was  10  s.  Background  images  (with  the 
discharge turned off) were subtracted and a low pressure mercury lamp was used to 
determine the slit function of the spectrometer. Entrance slit width was set to 85 μm 
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when  acquiring  emission  from  the  discharge  and/or  the mercury  lamp.  The  room 
temperature was 22°C throughout the spectroscopic measurements.  
As seen in Figure 30, the temperatures within the filaments of “continuous” and “pulsed” 
FE-DBD were found to be about 500 K and 300 K respectively by model fit to 2nd positive 
Nitrogen system. This method measures temperature based on radiation from the 
discharge. Since radiation is highest from the microfilament area we assume that the 
measured temperatures come from that region while gas temperature outside of the 
microfilament remains at room temperature. 
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Figure 30. Rotational and vibrational temperature measurements from a model fit to 2nd positive 
Nitrogen system; please note, “modeled data” curve was intentionally raised, otherwise it is invisible 
since the curve-fit is nearly perfect. 
As can be seen from Figure 30, during a microsecond pulse the gas does not heat up. 
However, there is sufficient time for streamer formation and development into filaments 
(see Figure 29). This way the discharge is more uniform than in the case of a sinusoidal 
excitation wave but still non-uniformity is observed as can be seen from the short exposure 
photograph through the water electrode below (Figure 31 and Figure 32). This way the 
treated surface is covered fairly uniformly in as little as a third of a second and below. 
However, for some applications a more uniform plasma treatment might be needed. For 
this we have developed a different power supply with shorter pulse duration. 
 
Figure 31. Photograph of plasma through water electrode. 1/3 second (0.33 sec) shutter open time. 
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Figure 32. Photograph of plasma through water electrode. 1/320 second (0.0031 sec) shutter open time. 
We have designed a system for the generation of high voltage, pulsed, periodic dielectric 
barrier or corona discharges capable of being used in the presence of conductive liquid 
droplets and over contaminated surfaces. This system can be used, for example, in different 
devices for generation of uniform dielectric barrier discharge plasma for treatment and 
sterilization of various uneven and contaminated surfaces. One of the main difficulties in 
the development of high voltage short pulsed power supplies is the matching of energy of 
the pulse generated by the power supply with the energy dissipated in the load. The other 
important problem is switching off of the high voltage switcher after the pulse subsides. 
Our so-called nanosecond-pulsed system solves both of these problems and gives us 
possibility to produce high efficiency generator of extremely short pulses with using 
reliable and simple pulse switcher like an uncontrolled spark gap. 
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The system is based on controllable fast charging of a capacitor and then discharging of 
this capacitor through a series of two spark gaps. This system was discussed in detail 
previously (see [165]) but the basic principle of operation is as follows. There are two 
spark gaps and the load connected in parallel with the second spark gap. When the first 
spark gap discharges, the voltage is applied then simultaneously to the second spark gap 
and the load. Thus, the voltage applied to the load is defined by the primary spark gap and 
the duration of the pulse is defined by the second spark gap. Additionally, time between 
these pulses is defined by the rate of charging of the capacitor. The result of the method is 
the formation of high voltage pulses with an extremely short rise time, for example, up to 
5-20 nanoseconds, and with high pulse repetition frequency, for example, up to 2,000 Hz. 
The high voltage pulses facilitate maximum efficiency plasma chemical oxidation of 
detrimental impurities, and increase the range of stable discharge operation in the presence 
of droplets of water or other conductive liquids in the discharge zone. Details of 
construction and operation of such a device have already been discussed earlier (see [168]). 
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Figure 33. Oscillogram of the nanosecond pulse voltage and current. Voltage rises to ~ 30 kV in ~ 10 
ns, or 3,000 V/ns. 
Figure 35 shows a result of application of ultra-short high voltage pulses to the FE-DBD 
setup in Figure 34. This setup allows to quickly move photographic film through plasma 
discharge. When the discharge is in pulsed mode and the time between pulses is kept 
sufficiently long (a few hundred Hz) we are able to get an image of a single pulse of 
plasma on the film plane. The result is a Lichtenberg figure of a completely uniform 
plasma field. Thus, this setup is able to generate a completely uniform and filament-free 
plasma at atmospheric pressure and temperature in open air, which can potentially be 
important for many applications where plasma discharge uniformity is of concern, for 
example in sterilization of living human tissue or in other applications (see, for example, 
[19, 26]). 
 
Figure 34. Diagram of a setup to capture a single pulse of Dielectric Barrier Discharge plasma on 
photographic film. 
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Figure 35. Image produced on black and white photographic film (100 ISO sensitivity negative film) by 
a single nanosecond pulse of DBD plasma. 
For comparison with the uniform plasma pulse produced by the nanosecond excitation 
(Figure 35) we are able to run the same experiment using the microsecond excitation 
pulses. The resulting Lichtenberg figure is shown in Figure 36. The microfilament pattern 
produced on film is identical to that predicted theoretically and observed experimentally in 
the past, and thus we can assume that we are in fact observing non-uniform plasma [147, 
148, 162]. Continuous excitation wave plasma looks similar on the film however since the 
plasma is on for a significant portion of the time the image on film results in something 
that is difficult to decipher unless the film movement speed is beyond that of the 
capabilities of our experimental setup. 
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Figure 36. Image produced on black and white photographic film (100 ISO sensitivity negative film) by 
a single microsecond pulse of DBD plasma. 
 
3.6. Summary of Direct with Indirect comparison of FE-DBD Plasma Application to 
Tissue 
By this point we have discussed the need for a non-thermal plasma treatment in Chapter 1 
and introduced such a system in Chapter 2. Various modifications of dielectric barrier 
discharges have already been used by other research groups in the past for surface 
modification without excessive damage to this surface (see [59, 61, 119, 124, 169-177] for 
examples). Our task, though, requires direct contact of plasma not with some polymer 
surface but with a living object. We showed that plasma can safely be put in contact with 
living tissue where charges are brought to the surface of the organism. This direct 
treatment was shown to achieve desired effect of sterilization orders of magnitude faster 
than in the case on indirect treatment by the plasma affluent. Here we understood by what 
means plasma is able to achieve this desired effect and showed that charged species 
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(electrons and positive and negative ions) are responsible for the effect. Neutral and 
excited species also must play an important role in inactivation of bacteria but the presence 
of charges is essential in achieving the desired effect, at least when the bacteria are treated 
in room conditions on skin or skin-like surfaces. In the following chapter we will discuss 
application of the FE-DBD plasma system in non-damaging skin sterilization of human 
cadavers, and live mice and pigs. 
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CHAPTER 4. DIRECT NON-DAMAGING TREATMENT BY NON-
EQUILIBRIUM PLASMA OF LIVING TISSUE: TOXICITY TRIALS 
 
A topical tissue treatment which induces damage would have a questionable medical use. 
Our goal in this chapter is to discuss the extent of damage, if any, FE-DBD plasma causes 
to tissue that it comes in contact with. Some medical treatments, i.e. sterilization of intact 
skin before surgery or needle insertion, would require no damage to skin, while other 
treatments, i.e. tattoo removal or removal of necrotic tissue from ulcer surface, would 
require some degree of precisely controlled damage. We also envision sterilization of open 
wounds and ulcerating wounds as one of the possible uses of FE-DBD plasma and thus 
extent of toxicity of the treatment under such conditions needs to be evaluated. 
To evaluate the extent of damage FE-DBD plasma treatment causes to tissue, we employ a 
method known as the “differential skin toxicity trial” [178-182]. In this method, we locate 
the dose at which damage can be clearly observed both visually and microscopically and 
then reduce the dose. Once the maximum dose at which no damage is observed is located, 
more treatments are made around that dose and statistical information is collected. Dose is 
determined by the combination of plasma power and treatment time; i.e. high power short 
treatment or low power long treatment. For example, if at 1 Watt/cm2 of plasma surface 
power density we observe no damage starting from 60 seconds of treatment then we repeat 
treatments on 3 samples each at 55, 60, and 65 seconds. If no damage is observed at 55 and 
60 seconds while some minor damage is visible at 65 seconds, then 60 second treatment at 
1 Watt/cm2 is deemed the maximum acceptable dose (here dose is 60 sec x 1 Watt/cm2 = 
68 
60 sec·Watt/cm2). It is a well-known fact in plasma surface processing that dose response 
is non-linear in most cases [61, 62, 119, 163, 174, 176, 183, 184]. We speak of “dose”, but 
we mean a combination of time and power; i.e. results obtained after 60 seconds of 
treatment at 1 Watt/cm2 may be drastically different from the results obtained after 30 
seconds of treatment at 2 Watt/cm2. Additionally, dose rate plays a significant role as well, 
meaning continuous application of plasma for 60 seconds compared with repeat bursts of 6 
seconds, 10 repetitions, with 60 second pause in between; or in the case of a pulsed plasma 
– the pulse frequency. Although those results were obtained and recorded they are not 
presented here and can be found in [19, 26, 185]. 
Initially, all experiments were performed on human cadaver skin tissue samples and 
discarded skin tissue3. The maximum acceptable treatment times were located for different 
plasma powers. These doses were then employed as the basis for our animal trials. First, 
we analyzed toxicity on SKH1 hairless mice, and then on regular swine. Following intact 
skin toxicity trials we moved on to a wound model on swine as their skin closely resembles 
that of human skin [178, 186-189]. In Section 3.1 we will discuss human cadaver skin 
trials, mice trials in 3.2, pig intact skin in 3.3 and wound model in 3.4. 
 
                                                 
3 Discarded tissue, according to our IRB protocol and agreement with the hospital is tissue 
which was removed from the patient and approved medical doctor deems no longer 
necessary for any tests. Examples of such tissues include skin tissue discarded during 
abdominal surgery, placenta tissue not wanted by the patient, tissue removed during plastic 
surgeries, wound debris, etc. 
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4.1. Skin Toxicity Trials on Human Cadaver Tissue 
Although human cadaver skin is a dead tissue, it does closely resemble skin of a living 
patient for the purpose of our initial physical investigation [190-192] – in our initial 
experiments we sought to find conditions under which a not perfectly polished skin-like 
substrate is not thermally or chemically disintegrated. At first we simply applied plasma to 
skin which was laying on a metal surface, but have quickly realized that such a setup leads 
to uncontrollable and rarely repeatable results. Figure 38 shows one such example where 
two different samples were treated at high power for 2 minutes each (Figure 37 – setup). 
The first sample (top) remained flat during treatment (as observed by eye during the 
treatment process); the second sample “bunched up” and touched the electrode in the 
center leading to a very non-uniform result. Obviously such a result is unacceptable, so we 
have devised a setup allowing for repeatable experiments (see below). 
 
Figure 37. Photograph of the FE-DBD treatment electrode with a “jacket” which allows for control of 
distance between electrode and treatment target. 
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Figure 38. Photographs and schematics of the results of 2 minutes of FE-DBD plasma treatment at 1.6 
W/cm2. Skin is laying on metal surface which leads to uncontrollable results: uniform treatment is 
some cases (top) and non-uniform in others (bottom). 
Modification of the above setup where tissue sample is held in place by vacuum suction 
was introduced and allowed us to obtain repeatable results. Figure 39 shows a schematic of 
the setup with the photographs of the perforations on the vacuum skin holder (circular skin 
sections were cut with a specialized tool we have manufactured for this purpose; it is 
similar to a basic cookie-cutter with very sharp edges). Figure 40 shows this setup in 
operation. The photo is dark to allow us to clearly see plasma. 
 
Figure 39. Schematic of the tissue treatment setup with vacuum suction and zoom photographs of the 
vacuum holder perforations. 
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Figure 40. Vacuum suction treatment setup in operation during plasma treatment. 
Our results confirm that there is no gross (visible) or histological (microscopic) damage to 
the treated skin and organ samples in as much as 5 minutes of treatment (Figure 41) while 
complete hospital-grade sterilization is achieved in less than 6 seconds of plasma 
treatment. Skin samples treated by plasma show no visible damage (Figure 41, top) and 
histological analysis shows no microscopic damage (Figure 41, bottom). 
For  treatment of human skin, explanted tissues and organs,  two  models  were 
constructed. In the first model, skin samples and organs were harvested from human 
cadavers;  in  the  second  model,  tissues  and  organs  discarded  during  surgery  were 
used. Neither model offers an insight into interaction of plasma with living organisms 
but  provides  us  with  data  on  plasma’s  ability  to  physically  damage  tissue  and/or 
sterilize bacteria  from  its  surface.  In  all  experiments  the  copper or water  electrode 
was fixed at a controlled distance from the treated tissue or organ either by means of 
micro‐positioners, where available, or by spacers glued to a hand‐held electrode. All 
tests were performed as soon as  the samples were obtained. Treated samples were 
photographed  then  stored  in  Formaldehyde  and  submitted  to  the  Pathology  lab 
72 
where  the samples were  fixed  in paraffin,  sectioned,  and  stained by Hematoxylin & 
Eosin (H&E) for microscopic analysis. Additionally, a small section of the sample was 
frozen  in  liquid  nitrogen  and  stored  at  ‐80°C  in  case  further  analysis  might  be 
desirable. 
 
Figure 41. Photos (top) and tissue histology (bottom) of cadaver skin samples after FE-DBD treatment: 
control (left), 15 seconds of treatment (center), and 5 minutes of treatment (right) – no visible damage 
is detected. 
 
4.2. Skin Toxicity Trials on Live Hairless Mice 
Following the investigation on cadaver tissue we initiated our first live animal trial. 
Although mouse skin is not as close to human skin as that of a pig, we have selected mice 
for the initial trial following a suggestion from a representative of Food and Drug 
Administration (FDA) and the Institutional Animal Care and Use Committee (IACUC) 
members – since a pig model was also planned at that time, to minimize the overall 
73 
experimental matrix, the use of a smaller animal model was recommended to us prior to 
toxicity trial on larger species. 
Regular healthy mice were selected at first; however, we quickly found out that shaving 
them causes noticeable skin irritation and thus introduces further experimental variability 
(Figure 42). SKH1 mice from Charles River Laboratories proved then to be an excellent 
experimental subject. They are not immunodeficient – some mouse models with 
suppressed immune systems are hairless as a side effect of genetic modification while 
SKH1 mice are simply hairless but otherwise quite healthy and immunocompetent (Figure 
43). 
 
Figure 42. Photograph of a regular mouse during hair shaving procedure. Post shaving the skin 
appears to be quite irritated and thus the model is not usable for a skin toxicity trial. 
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Figure 43. Photograph of a Charles River Laboratories SKH1 hairless mouse immediately after arrival 
at the animal care facility. 
Mice were anesthetized using Isoflurane gas inhalation and remained anesthetized 
throughout the procedure. Some animals were euthanized by CO2 asphyxiation while 
others were placed on a warming blanket and allowed to wake up for post-surgery 
observation. During plasma treatment animals were fixed using tape to minimize 
movement and the plasma electrode was attached to a flexible holder which can be 
adjusted in all dimensions and then fixed in desired position. We have also attached a 
fixed-thickness perforated ceramic spacer to the electrode to ensure precise distance 
between the animal and the electrode (Figure 44 – power supplies, Figure 45 – general 
schematic of the electrode setup, and Figure 46 – example photograph of the animal 
immediately following treatment). 
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Figure 44. Photograph of two power supplies (microsecond pulsed and continuous sinusoidal) with the 
small 10 mm diameter electrode for treatment of mouse skin. 
 
Figure 45. Schematic of the 10 mm diameter copper electrode with attached perforated spacer for 
controlled treatment of a mouse. 
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Figure 46. Photograph of an animal immediately following treatment. The perforated spacer is left on 
the area of treatment to mark it for later sample harvesting. Areas 1 and 2 have already been treated, 
in this particular case for 75 seconds at 0.3 Watt/cm2 surface power density by microsecond pulsed 
power supply. No damage to skin is observed visually. 
Based on the experimental matrix, a dose of 10 minutes at 0.6 Watt/cm2 was determined as 
maximum acceptable prolonged treatment and a dose of 40 seconds at 2.3 Watt/cm2 was 
determined as maximum acceptable high-power treatment. Histological (microscopic) 
comparison of control SKH1 skin sample with toxic and non-toxic plasma doses show 
regions where plasma dose is high while the animal remains unaffected (Figure 47 – 
histological samples, Figure 48 – animal after the treatment). Of note is that sterilization 
was achieved at 2 to 4 seconds at high-power treatment of 0.8 ±0.2 Watt/cm2 and at 10 
±4.4 seconds at half that power. 
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Figure 47. Histology of toxic and non-toxic to SKH1 skin plasma doses, compared to untreated skin. 
 
Figure 48. Animal remains fine immediately after a high plasma dose (more than 10 times higher than 
needed for skin sterilization). 
To test if the treatment has some longer-term effect which is not immediately visible we 
have left a portion of animals alive for up to two weeks. Figure 49 shows the same animal 
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from Figure 48 two weeks following the treatment. There is no apparent visible change to 
the treated area and histological samples show no damage to skin as well. 
 
Figure 49. Animal remains fine two weeks following a high plasma dose (more than 10 times higher 
than needed for skin sterilization). 
 
4.3. Skin Toxicity Trials on Live Regular Swine 
Following the toxicity trial on mice we moved on to a large animal model utilizing for it 
regular swine. Pig skin resembles closely that of humans and thus makes for a good animal 
model of skin toxicity [178, 186-189]. The experimental setup is essentially the same as 
for mice, the main difference being that we made a much lighter electrode and taped it to 
the animal rather than positioning it using a 3D holder as was done for mice and cadaver 
tissue (Figure 50). 
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Figure 50. 3D schematic of the electrode used for swine skin experiments. 
The electrode design based on the initial idea shown in Figure 50 has proven to be too 
heavy to be held up to animal skin by tape and thus we have removed Teflon coating 
replacing it (for electrical safety) with a layer of glue (Figure 51). This small modification 
does not change the results this electrode is able to achieve as the plasma remains the 
same, but the electrode weight is reduced enough so that it can be securely attached to the 
animal skin by tape. This becomes useful mainly for the cases of prolonged treatment (over 
30 seconds). This also offers an insight into future electrode designs. When the treatment 
will be performed on an actual human patient, especially if he or she is not anesthetized 
and is able to move freely, the treatment time needs to be kept below a few seconds for a 
hand-held electrode. For treatments longer than that the system needs to be designed to 
securely hold the electrode to the patient allowing him or her to move freely while the 
skin-to-electrode distance remains fixed. 
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Figure 51. Photograph of the modified FE-DBD electrode attached to animal skin using tape. 
Based on our experience with SKH1 hairless mice described in the previous section we 
have performed a series of similar experiments on intact skin of regular swine. For all 
treatments we have selected a microsecond pulse plasma excitation power supplies. To 
assess dose rate dependence of these treatments we have utilized four different pulse 
frequencies identified in Table 5. We refer to these later in the text as ranging from high 
dose rate (“Setting 4”, 1,500 Hz) to low dose rate (“Setting 1”, 500 Hz). 
Table 5. Plasma power supply settings used in the swine skin treatment experiments. 
Label Pulse 
frequency 
Surface power 
density 
Setting 1 500 Hz 0.13 Watt/cm2 
Setting 2 800 Hz 0.19 Watt/cm2 
Setting 3 1,000 Hz 0.25 Watt/cm2 
Setting 4 1,500 Hz 0.31 Watt/cm2 
 
A good example of a high dose treatment (low dose rate, Setting #1, but long time) wound 
be treating an animal for 10 minutes. At this dose rate we observe inactivation of bacteria 
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on agar, human cadaver skin, and on mice in under 10 seconds (5 seconds leads to 7 log 
reduction in viable bacteria) [26]. Treatment for longer than 10 seconds would show it to 
be not only effective but also safe. We were able to treat animal skin for up to 10 minutes 
without any damage to it apart from mild inflammation that disappears within a few 
minutes following treatment. For this we locate healthy section of the tissue (Figure 52), 
shave it, mark the location where the electrode will be attached, take the electrode to the 
tissue and turn on the plasma. Immediately following the treatment we do observe a slight 
skin inflammation which can be seen in Figure 52 on the right as compared to Figure 52 on 
the left which is a photograph of the same section of the skin but prior to treatment. The 
time between these two photographs is approximately 10 minutes and 15 seconds – as soon 
as the initial photo is taken the electrode is attached and the plasma treatment commences; 
the after treatment photograph is taken a few seconds following the electrode removal, or 
as soon as the camera is positioned correctly and focused on the specimen. 
  
Figure 52. Photograph of the animal skin prior (left) and immediately following a 10-minute FE-DBD 
treatment at low frequency Setting #1 (right). A mild skin inflammation is visible immediately after the 
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treatment (shown) which disappears within a few minutes following the treatment (not shown). Black 
markings on the skin indicate position of the edge of the treatment electrode (for skin sample 
harvesting purposes). 
The inflammation we refer to here is barely visible on the photograph while is more 
apparent in real life to a human observer directly near the wound. This inflammation 
disappears quickly following the treatment. The skin is then harvested and sent for H&E 
histological staining and later sectioning following the same protocols as discussed above 
for human cadaver and SKH1 mice. Figure 53 shows the result of this staining of the above 
skin sample treated for 10 minutes. As can be seen from this image, there is no tissue 
damage and/or inflammation; in other words, this skin sample appears the same as an 
untreated control sample. 
 
Figure 53. H&E histological stain of the skin sample treated for 10 minutes at low frequency Setting #1 
(Figure 52). No microscopic damage to skin can be seen. 
The positive control for this treatment is done with the state-of-the-art Bovie® knife which 
resistively heats up the tissue by passing current through it causing tissue desiccation, 
inflammation which is immediately visible (compare with 10 minutes of plasma treatment 
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in Figure 52), and overall severe tissue damage. Figure 54 shows the result of such a 
treatment where excessive damage is clearly seen. 
 
Figure 54. Photograph of the animal skin immediately following treatment by Bovie® knife (positive 
control) – excessive skin damage, desiccation, and inflammation are clearly visible. 
Overall results of the skin toxicity trials on pigs are similar to those on human cadaver skin 
and on SKH1 mice – only rather high doses of plasma, those far greater than needed for 
sterilization or blood coagulation, are able to damage skin; while doses required to achieve 
desired medically relevant therapeutic effect are significantly below the damage threshold. 
 
4.4. Wound Toxicity Trials on Live Regular Swine 
One of the potential applications of FE-DBD plasma treatment is sterilization of wounds 
and/or coagulation of bleeding capillaries (see end of section 2.2 above). We were able to 
test the efficacy and toxicity of such treatment on a superficial partial thickness skin wound 
similar to that of scraping one’s knee. Once the animal was anaesthetized the wound was 
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made with a small hand-held dermatome knife (Zimmer, Franklin County, OH, USA) 
originally designed to remove precise-thickness skin grafts from a donor patient (Figure 
55). Although the hand-held version of this device is difficult to master4 for precise skin 
graft removal, the wounds that we were able to create with this blade appear to the eye 
closer to the actual wounds that FE-DBD plasma would potentially be treating – they have 
a torn texture similar to that of a deep scrape wound one gets falling from a bicycle, for 
example (see Figure 55). These are partial thickness wounds with the blade set to cut no 
deeper than a millimeter into the skin. This exposes the top layer of skin and breaks 
capillaries located in the skin, but not the bigger vessels. Thus, the bleeding is slow and 
manageable. The zoom in on the wound demonstrates a typical wound we are able to 
induce with this procedure. This is not a severe wound and the bleeding would normally 
self-terminate quickly. Immediately after the wound is made we proceed with the selected 
treatment. 
                                                 
4 For taking actual skin grafts, Zimmer recommends their automatic knives which are 
driven by compressed air and have proven themselves to be quite a bit more precise than 
the hand-held version. 
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Figure 55. Photograph of a process of making a partial thickness skin wound with a dermatome knife 
(left) and a zoomed in photograph of the resulting wound immediately prior to the FE-DBD plasma 
treatment. 
Similar to the intact skin, treatment with Bovie® knife quickly coagulates blood and 
desiccates the tissue but causes quite significant damage (see Figure 56, left). Although the 
wound may be closed, there is a significant level of tissue damage which may prolong the 
wound healing process over that if the wound was simply left with no treatment in this 
case. While Bovie® electrosurgery knife causes significant tissue damage, FE-DBD 
plasma treatment can be applied to the tissue for up to 15 minutes with minimal damage to 
this tissue (Figure 56, right), similar to what was observed above with treatment of intact 
skin. One other observation is that even after a short treatment, the blood appears to be 
coagulated and (although this is not visible on the photograph below) the wound looks to 
be covered with a thin layer of clear coagulum. We have seen such a thin transparent cork 
formation before with treatment of blood and blood plasma samples [19, 193]. This film 
was claimed to be a thin layer of coagulated blood plasma – FE-DBD seems to quickly 
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form a layer of coagulated blood on the surface of the wound which protects the wound 
from further external disturbances. 
   
Figure 56. Photograph of a positive control treatment with Bovie® knife (left) where the tissue is 
clearly desiccated and blood is clotted but the tissue damage is quite extensive. Compared to a 
photograph of a wound treated by FE-DBD plasma for 15 minutes in low power Setting #1 (right) 
where no significant tissue damage is observed and a layer of coagulated blood is formed over the 
wound surface. 
Results of the various FE-DBD plasma treatments of wound surface are detailed in Table 6 
and Table 7, and histological images of these skin samples are shown in Figure 57 and 
Figure 58 respectively. The overall observation is that at a low dose rate (Setting #1) we 
are able to treat the skin surface for prolonged time periods without seeing significant 
tissue damage; while, as expected, at high dose rates we are able to achieve coagulation 
and wound closure much faster, along with the tissue damage. 
Table 6. Results and analysis of FE-DBD plasma treatment of wound surface. 
Label Treatment Group Gross observations 
during surgical 
treatment (cm) 
Histology analysis (blinded 
to specimens) 
1 Bovie knife 
(positive control) 
2.5 x 1.0 area of effect, 
eroded 
Disruption of epidermis and 
papillary dermis, areas of 
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dermis coagulated, no dermal 
nuclei, hair follicles still intact 
2 No treatment 
(negative control) 
No change, normal skin No change, normal skin 
3 3 min, setting 4 2 x 2 area of effect, 
mottling 
Similar to bovie, burn through 
to dermis 
4 3 min, setting 4 2 x 1.5 area of effect, 
pigmented, irregular, 
raised 
Similar to bovie, burn through 
to dermis, slightly more than 
label 3 
5 3 min, setting 3 0.5 x 0.7 area of effect, 
pigmented 
Similar to bovie, burn through 
to dermis 
6 3 min, setting 3 1.5 x 1.5 area of effect, 
some pigmentation, 
mottling 
Burn through to epidermis, 
small area of congestion in 
dermis 
7 3 min, setting 2 1.5 x 1.2 area of effect, 
lightly mottled 
Small area of burn in 
epidermis, most skin here is 
intact 
8 3 min, setting 2 2 x 1.5 area of effect, 
lightly mottled 
Small area of burn in 
epidermis 
9 15 min, setting 1 2.5 x 2 area of effect, 
lightly mottled 
Small area of burn in 
epidermis 
10 15 min, setting 1 2.5 x 3 area of effect, 
lightly mottled 
Small area of burn in 
epidermis 
Ends 
of 1-
10 
All edges of the 
specimens (1-10) to 
assess for zone 
effect 
No change, normal skin All show normal skin, no zone 
effect 
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Figure 57. Results of H&E histological stain for samples described in Table 6. 
 
Table 7. Results and analysis of FE-DBD plasma treatment of wound surface. 
Label Treatment Group Gross observations 
during surgical 
treatment 
Histology analysis (blinded 
to specimens) 
1 Bovie Eschar formation, burn 
formation immediately 
after treatment Instant 
blood coagulation 
Necrotic tissue 
Necrosis deep in the dermis. 
Disruption of the dermis. No 
dermal nuclei. Hair follicles 
still intact 
1B0 Control wound Normal wound No change to wound 
2 High Frequency 3 
min 
Blood clot formation, no 
necrotic tissue no burn 
No damage to dermis. Looks 
like normal wound. No 
damage to hair follicles. 
3 Low Frequency 3 
min 
Blood clot formation. No 
burn 
Looks normal. No damage to 
dermis. Hair follicles intact. 
Clot formation 
4 High Frequency 1 Clot formation. No burn Looks normal. Practically no 
89 
min to wound damage to tissue. No damage 
in dermis. Hair follicles intact 
5 Low frequency 1 
min 
No burn. Clot formation No damage. No tissue 
damage. Hair follicles intact. 
Clot formation on the surface 
of the wound 
6 High Frequency 30 
s 
No burn. Clot formation Practically no damage to 
tissue. No damage in dermis. 
Clot formation 
7 Low Frequency 30 
s 
No burn. Clot formation Practically no change. No 
damage. Clot formation 
8 High Frequency 5 s No burn. Clot formation Practically no change. No 
damage to dermis. No damage 
to tissue. No clot formation 
9 Low frequency 5 s No burn. Clot formation No damage. Clot formation. 
No damage in dermis 
10 High Frequency 3 
min 
Blood coagulation. No 
burn observed 
Practically no damage to 
dermis. Intact hair follicles 
11 Low Frequency 3 
min 
No burn. Clot formation 
observed 
No damage to dermis. Intact 
hair follicles. No necrotic 
tissue 
12 High Frequency 1 
min 
No burn. Clot formation Clot visible. No damage to 
dermis. Intact hair follicles. 
13 Low frequency 1 
min 
No burn observed. Clot 
formation immediately 
after treatment 
No damage to dermis. 
Practically no change 
14 High Frequency 30 
s 
Clot formation. No burn 
observed 
Clot on the surface. No 
damage to dermis. No change 
15 Low Frequency 30 
s 
No burn observed. Blood 
clot formation 
Clot on surface. No damage to 
wound tissue. Intact hair 
follicles 
16 High Frequency 5 s No change in the wound 
observed 
Clot on the surface of the 
wound. No damage to wound 
tissue. 
17 Low frequency 5 s No change in the wound 
observed 
No change. Practically no 
damage 
18 Control wound Normal wound No change 
18B+ Bovie Eschar formation. 
Immediate coagulation 
Burn in the dermis. Necrotic 
tissue. Lack of dermal nuclei. 
Damaged tissue. Disruption of 
the dermis 
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Figure 58. Results of H&E histological stain for samples described in Table 7. 
 
4.5. FE-DBD Treatment of Living Tissue: Next Steps 
Application of non-equilibrium plasma to cells and tissues has been shown to be quite 
selective in inactivation of pathogens, sterilization, and promotion of complex biological 
responses with minimal or no damage to the treated tissues and cells. Details of such 
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selectivity with data from many groups around the world are discussed in detail by the 
authors in a recent review [26]. Based on our own experimental data presented above with 
cadaver tissue, living mice, living pigs, and data reported on previously with cell cultures 
of various mammalian cells (macrophages, epithelial cells, b-lymphocytes, fibroblasts, and 
melanoma cancer cells) we can thus-far deduce three major hypotheses for the reasons of 
the observed selectivity: 
1. Metabolism of reactive oxygen species (ROS) is difference in prokaryotic (i.e. 
bacteria) and eukaryotic (i.e. mammalian) cells; i.e. while human cells have 
protection from species like Oଶି  (superoxide) bacteria either lack it completely or 
the resistance is lower. 
2. Higher order organisms have developed more resistance mechanisms to external 
stress (osmotic pressure changes, ROS, chemical and biological poisons, etc); in 
other words, bacteria usually act as a single cell while mammalian cells, especially 
those organized into tissues, communicate with each-other possibly lowering the 
effects of the applied poison. 
3. Bacterial cells are usually much smaller than mammalian cells and thus have much 
higher surface to volume ratio; i.e. simply a lower dose of poison is required to 
inactivate same number of bacteria vs. mammalian cells. 
These hypotheses are of course quite phenomenological and further detailed testing is 
required to claim them to be true. However, authors are continually receiving evidence in 
support of these ideas [19, 26, 27, 109, 143, 193-197]. 
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Radiation biology studies biological effects of ionizing and non-ionizing radiation of the 
whole electromagnetic spectrum. Our concern is primarily with the penetrative ionizing 
radiation resulting from radioactivity (alpha, beta, and gamma) and x-rays. Here 
radiobiology claims that the main mechanism of action on a cell is through formation of 
reactive oxygen species directly in the vicinity of a DNA molecule inside a cell nucleus 
[198, 199]. The ROS of interest here are hydroxyl radicals (OH), hydrogen peroxide 
(H2O2), and the superoxide anion (Oଶି ). A stain for DNA double strand break, the same test 
used in radiobiology, shows that the damage does, in fact, occur but is repaired by the cell 
rapidly and the cell recovers [200]. 
FE-DBD plasma used in this treatment is a gas-phase phenomena and is not generally 
known to penetrate liquids, unlike radiation does. So, what is it in plasma that is able to go 
through liquid? Mechanism of action is likely through same ROS as in radiobiology but 
these ROS are not generated at the vicinity of a DNA molecule but rather are transported to 
it through a series of mechanisms already present in cells. Example of such a mechanism is 
as follows. First, a superoxide anion is generated from hydrated electrons deposited into 
the liquid from plasma: eሺHమOሻ ൅ OଶሺHమOሻ ื OଶሺHమOሻି . Mammalian cells have a mechanism 
of defense against superoxide and immediately converts it into less harmful hydrogen 
peroxide through a reaction termed “superoxide dismutation” which is catalyzed by an 
enzyme appropriately termed superoxide dismutase (SOD): 2Oଶି ൅ 2Hା ሾSODሿሱۛ ሮۛ HଶOଶ ൅Oଶ. 
Hydrogen peroxide can then travel through liquid (and we do see quite high concentrations 
of it in liquid cell growth media). At appropriate conditions, hydrogen peroxide is 
converted to hydroxyl radicals through a natural reaction chain termed Fenton mechanism 
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(where M+ is any ion coming to liquid from plasma, for example Nଶା which is abundant in 
air plasma [201]): 
HଶOଶ ൅ Feଶା ื OH൅ OHି ൅ Feଷା 
Feଷା ൅ Oଶି ื Feଶା ൅ Oଶ 
Mା ൅ HଶO ื M൅HଶOା 
HଶOା ൅ HଶO ื HଷOା ൅ OH 
Hydroxyl radicals may then react with nearby organics leading to chain oxidation and thus 
destruction of DNA molecules as well as cellular membranes and other cell components 
(here R is some organic molecule): 
OH ൅ RH ื R൅ HଶO 
R ൅ Oଶ ื ROଶ 
ROଶ ൅ RH ื ROଶH ൅ R 
Another potential mechanism is through change of ionic force of solution surrounding the 
cells by plasma ions. Plasma in this case simply acts as source of excess charges, similar to 
adding acid or salt in the vicinity of the cell thus changing osmotic pressure which leads to 
pore formation, cell leakage, and possibly death. We can estimate N2+ ion concentration 
from ionic flux to the treated surface at the electric plasma specific power of 1 W/cm2: 
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here Φ is the ion flux, P is specific power, and GN2+ is the “G-factor” for Nitrogen ion 
production in electric discharge – number of Nitrogen ion produced per 100 electron-Volt 
(eV). In this simplified model, we are assuming that every N2+ ion produced in the plasma 
volume reaches the liquid surface. Plasma treatment area is a 2 cm diameter circle so the 
treated area is 3.14 cm2. From here we can see that the total number of ions produced per 
second is 6*1016. This is an excessively high number but gives us an idea of an order of 
magnitude of ions coming to the vicinity of the bacterial cell during treatment. Although 
significant further work is needed in this direction, initial indication of a possibility of 
influence of ionic force of solution in cell’s lifecycle is apparent and will be further 
investigated in the future.  
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CONCLUDING REMARKS 
 
The main novel contributions of this thesis are: 
 Development of a new non-thermal atmospheric pressure plasma discharge which 
can be applied directly to living tissue without painful sensations or visible 
damage; 
 Demonstration of high efficiency of this discharge in deactivation of bacteria on 
surfaces of living tissue and those that mimic living tissues; 
 Demonstration that the discharge parameters related to its uniformity, temperature, 
generation of active can be partly controlled via the shape of the applied voltage 
waveform; 
 Demonstration that no visible tissue damage of intact skin and scraped wounds 
occurs for discharge doses that are much higher than those required to reduce 
bacterial load by over 6 orders of magnitude; and 
 Demonstration that high efficiency of the direct application of the non-thermal 
plasma is mainly due to contact of infected surfaces with charged species in plasma 
in the presence of oxygen. 
The work carried out in this thesis contributes to the recent trend of using plasma in 
medicine not only for tissue ablation or cauterization, but also for much more subtle 
modalities of medical therapy. Medical applications of 'cold' plasmas such as tissue 
sterilization, treatment of corneal infections, blood coagulation, treatment of cancers, 
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leishmaniasis, treatment of dental diseases and others are in the beginning stages of their 
development. Though preliminary results are very promising, bringing 'cold' plasmas into 
medical practice will not be very easy. Besides the usual safety concerns, the main obstacle 
remains the lack of understanding on molecular and biological levels of mechanisms of 
interaction between non-thermal atmospheric pressure plasma and living cells, tissues, 
organs, and the whole organism. While it is clear that direct interaction with hot plasma 
occurs mainly through heat transfer, interaction with non-thermal plasma in general may 
depend on a myriad of variables including various charged species, electric field, UV, 
radicals, electronically excited atoms and molecules. Complex synergies may be 
responsible for different effects. Not only dose, but the effects of dose rate may be of 
critical importance for treatments. Fundamental studies in the area of plasma medicine are 
further complicated by the true interdisciplinary nature of investigations that are required. 
Although many challenges remain, this work clearly reveals the enormous potential of the 
non-thermal plasma technology in medicine. The growth of this technology will probably 
continue in the near future not only because the payoffs are substantial, but also because 
plasma is one of the few remaining areas of modern technology whose application in 
medicine has been barely explored.  
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